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Abstract
Early life stress, sleep disturbances and alterations in neuronal plasticity 
have been associated with depression, yet the relation between these factors and 
depression remain poorly understood. This project explored the interconnection 
between depression and sleep disturbances, starting from early stage of development. 
Possible molecular mechanisms (such as brain derived neurotrophic factor (BDNF) 
and adenosine) underlying this interaction were assessed using animal models. The 
investigation of sleep disturbances in early-onset depression in humans was performed 
in depressed adolescents. The association between BDNF gene polymorphism 
(Val66Met) and the development of sleep was studied using a birth cohort. 
First, we investigated the epigenetic mechanisms of BDNF gene regulation 
during spontaneous sleep and after sleep deprivation using methylated DNA 
immunoprecipitation in rats. We showed that the dynamics of BDNF transcription 
during spontaneous sleep-wake cycle in brain areas crucial for sleep regulation 
(basal	forebrain	(BF)	and	frontal	cortex)	is	partially	regulated	by	brain	area	specific	
DNA methylation, and that the degree of sleep deprivation-induced BDNF up-
regulation is transcript- and brain area-dependent. 
To	assess	the	effect	of	early	life	stress	on	sleep	and	possible	mechanisms	of	
this	effect,	we	used	cross-fostering	in	rats.	Long-term	polysomnographic	recordings	
in	undisturbed	and	sleep	deprived	rats	were	performed	to	assess	sleep	profile.	In 
vivo microdialysis during spontaneous sleep with following high-performance 
liquid chromatography was performed to assess adenosine level in the BF. BDNF 
gene expression in the involved brain areas was determined by quantitative PCR. 
Behaviour	was	assessed	using	open	field	and	sucrose	preference	tests.	The	results	
indicated that early life stress induced by cross-fostering procedure produce 
negligible phenotypic alterations during adolescence or in adult rats. Cross-
fostered rats demonstrated, however, clear changes in sleep architecture. Rapid eye 
movement	(REM)	sleep	was	affected	the	most:	duration	and	number	of	its	episodes	
was	 significantly	 increased	 in	 cross-fostered	 rats.	 Moreover,	 cross-fostering	 led	
to persistent molecular changes in the brain, which was evidenced by decreased 
adenosine level during spontaneous sleep-wake cycle and by a tendency towards 
lower BDNF gene expression in the BF. 
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Further, to investigate sleep disturbances in early-onset depression we 
studied macro- and microarchitecture of sleep in depressed adolescent boys 
using polysomnography. Slow-wave activity (SWA) dissipation and rise rate were 
assessed and compared to age-matched controls. The sleep of depressed boys was 
characterized	by	lower	SWA	and	its	slower	rise	during	the	course	of	first	non-REM	
(NREM) sleep episode compared to healthy boys. The dissipation (decline from the 
first	to	the	third	NREM	episode)	of	SWA	through	the	night	in	depressed	patients	
had	flatter	shape	compared	to	healthy	subjects.	Moreover,	a	negative	correlation	
between SWA dissipation and depression severity was detected. All the changes 
were more pronounced in the frontal derivation compared to central derivation 
that support the idea that sleep regulation and depression might share common 
neurobiological mechanisms. 
To examine whether the BDNF Val66Met polymorphism can predispose 
individuals to depression and sleep disturbances Finnish CHILD-SLEEP birth 
cohort (n=1678) was used. The association between this polymorphism and early 
life development in infants of 3 and 8 months of age was assessed. Genotyping was 
done	with	Illumina	Infinium	PsychArray	BeadChip.	The	developmental	parameters	
(e.g. sleep, psychomotor development, temperament) were assessed by using 
specific	questionnaires.	We	found	no	robust	association	between	BDNF Val66Met 
polymorphism and studied parameters during early postnatal life of infants.
In summary, early life stress leaves persistent molecular trace in the brain, 
and sleep appears to be one of the most prominent indicators of early stressful 
events. Early life onset depression is characterized by changes in sleep macro-and 
microarchitecture that are associated with depressive symptoms severity. Although 
BDNF is playing an important role in sleep and mood regulation, its Val66Met 
polymorphism is not associated with development of these parameters during 
early stages of life.
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Abstract in Finnish 
Uni ja depressio: kehityskulkuja ja mekanismeja 
Masennukseen liitetään usein varhaisen kehityksen aikainen stressi, 
univaikeudet ja hermoston plastisuuden muutokset, mutta näiden tekijöiden 
ja depression suhde tunnetaan kuitenkin huonosti. Tässä työssä tutkittiin 
masennuksen ja unihäiriöiden välisiä yhteyksiä keskittyen varhaiseen kehitykseen. 
Molekyylitason mekanismeja (kuten brain derived neurotrophic factor, BDNF, ja 
adenosiini) tutkittiin eläinmallien avulla, unihäiriöiden esiintymistä varhaisessa 
depression vaiheessa tutkittiin teini-ikäisillä pojilla, ja unen kehityksen ja BDNF 
geenin	polymorfismi	Val66Met:in	välistä	yhteyttä	syntymäkohortin	avulla.	
Tutkimme aluksi rotilla BDNF geenin epigeneettistä säätelyä normaalin 
unen ja unen puutteen aikana käyttäen DNA:n immunosaostusta. Osoitimme, että 
BDNF geenin luentaa eri unta säätelevillä aivoalueilla (etuaivojen pohjaosa, BF ja 
etuaivokuori) säätelee osittain aivoalueille tyypillinen DNA:n metylaatio, ja että 
unen puutteen aiheuttama BDNF geenin luennan lisäys riippuu sekä aivoalueesta 
että BDNF:n geenikopiosta.
Tutkiessamme varhaisen stressin vaikutusta myöhempään unen kehitykseen ja 
vaikutuksen mekanismeja, käytimme uutta stressimallia: poikasten vaihtoa emojen 
välillä	 (cross-fostering).	 Uniprofiilin	 selvittämiseksi	 suoritimme	 aivosähkökäyrän	
ja lihasjänteyden määrityksiä varhaisnuorilla ja aikuisilla rotilla. Suoritimme myös 
in vivo mikrodialyysin adenosiinimäärityksiä varten; BDNF geenin ilmentyminen 
määritettiin eri aivoalueilta. Käyttäytymistä, erityisesti masennuksen merkkejä 
etsien, tutkittiin avokenttätestillä sekä sokerijuomatestin avulla. Tuloksista ilmeni, 
että varhaisen kehityksen aikainen, stressi (poikasten vaihto) ei näytä vaikuttavan 
eläinten masennuksena tulkittavaan käyttäytymiseen varhaisnuoruudessa tai 
aikuisena. Kuitenkin se aiheutti merkittäviä muutoksia erityisesti REM uneen: 
REM unijaksojen lukumäärä ja pituus olivat lisääntyneet. Aivoissa havaittiin myös 
molekyylitason muutoksia: adenosiinitaso oli laskenut ja etuaivojen pohjaosan 
(basal forebrain) BDNF:n ilmenemisessä oli taipumus mataliin arvoihin.
Selvittääksemme unen häiriöitä varhain alkaneessa masennuksessa 
mittasimme	 polysomnografiaa	 käyttäen	 unen	 mikro-	 ja	 makrorakennetta	
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teini-ikäisillä pojilla. Tutkimme hidasaaltoaktiviteetin (SWA) vähenemistä 
ensimmäisestä viimeiseen NREM unijaksoon (SWA dissipaatio) sekä SWA:n 
nousua ensimmäisen NREM unijakson aikana ja vertasimme näitä terveiden 
poikien vastaaviin arvoihin. Totesimme, että masentuneilla pojilla SWA oli 
kokonaisuudessaan madaltunut ja kasvu ensimmäisen NREM jakson aikana 
hidastunut. SWA dissipaatio oli latistunut ja madaltuma korreloi masennuksen 
vakavuuden kanssa. Kaikki muutokset havaittiin voimakkaimpina etuaivolohkon 
mittauksissa verrattuna muiden aivoalueiden mittauksiin, vahvistaen käsitystä 
siitä, että unen häiriöillä ja masennuksella voi olla yhteisiä säätelymekanismeja. 
Tutkimuksessa	BDNF	Val66Met	polymorfismin	merkityksestä	altistumisessa	
masennukselle ja unen häiriöille käytimme suomalaista CHILD_SLEEP 
syntymäkohorttia	(n=1678).	Tämän	polymorfismin	korrelaatiota	erilaisiin	varhaisen	
kehityksen mittareihin tutkittiin 3 ja 8 kuukauden iässä. Genotyypitys suoritettiin 
Illumina	 Infinium	 PsychArray	 BeadChipillä.	 Kehitystä	 kuvaavia	 suureita	 (esim.	
uni, psykomotorinen kehitys, temperamentti) selvitettiin kyselylomakkeiden 
avulla.	 Työssä	 ei	 löytynyt	 vahvaa	 yhteyttä	 BDNF	 geenin	 polymorfismien	 ja	
kehityssuureiden välille. 
Yhteenvetona voidaan todeta, että varhain koettu stressi jättää aivoihin 
pysyvän molekyylijäljen ja että uni/unen häiriöt näyttävät olevan herkin mittari 
varhaisen stressin vaikutuksien toteamisessa. Varhain alkavassa masennuksessa 
nähdään unen sekä mikro- että makrotasolla muutoksia, jotka korreloivat 
masennuksen vakavuuteen. Vaikka BDNF:llä on tärkeä rooli sekä unen että 
kehityksen	 säätelyssä,	 sen	 Val66Met	 polymorfismi	 ei	 näytä	 vaikuttavan	 unen	
häiriöiden tai masennuksen syntyyn kehityksen varhaisessa vaiheessa. 
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11. Introduction
Major	 depressive	 disorder	 (MDD)	 affects	 about	 15%	 of	 the	 population	 at	
some point in their lives and by the year 2020, MDD is estimated to be the second 
leading cause of world disability (Bromet et al., 2011; Kessler, 2007). One of the 
key symptoms of depressive disorder is sleep disturbance (Nutt et al., 2008). Up 
to	 90%	of	patients	who	suffer	 from	an	acute	depressive	episode	 report	changes	
in their sleep. Moreover, people with persistent sleep problems have elevated risk 
of developing psychiatric disorders, including depression (Breslau et al., 1996). 
Among the whole range of psychiatric disorders, MDD has the strongest lifetime 
association with sleep disturbances (Breslau et al., 1996). Thus, depression and 
sleep disorders have complex and reciprocal relationships.
Early life stress is one of the important predisposing factors for depression 
(Arnow, 2004). The incidence of depressive disorder increases promptly from 
childhood to adolescence (Newman et al., 1996; Oldehinkel et al., 1999) and then 
frequently recurs or persists into adulthood (Newman et al., 1996; Pine et al., 
1999; Sagatun et al., 2016). Adverse experiences during early stage of life, such as 
physical, or emotional abuse, neglect, or loss of a parent and poor child-parent 
relationships, are important susceptibility factors for development of MDD in 
adulthood, as evidenced by both epidemiological studies and experimental studies 
using	animal	models	(Heim	&	Nemeroff,	2001;	McCormick	et	al.,	2008).	Notably,	
sleep disturbances associated with early life negative experiences can persist 
for	years	 after	 the	 stressful	 events	 (Chapman	et	 al.,	 2011;	 Greenfield	et	 al.,	 2011;	
Koskenvuo et al., 2010). 
Emerging	evidence	 links	deficits	or	 impairment	 in	synaptic	and	structural	
plasticity to mood disorders (Castren et al., 2007; Duman, 2002; Dwivedi, 2009). 
The abnormal neural plasticity may be related to alterations in the levels of 
neurotrophic factors; especially brain-derived neurotrophic factor (BDNF), which 
plays a central role in neuronal and synaptic plasticity. Changes in the BDNF levels 
have been implicated both in the aetiology of depression and in antidepressant 
drug action (Castren & Rantamaki, 2010). Importantly, this molecule has also 
been shown to play an important role in sleep regulation and the level of BDNF 
expression	is	fluctuating	depending	on	the	vigilance	sate	(Cirelli	&	Tononi,	2000a;	
2Hairston et al., 2004). So, BDNF might be an important “bridge” connecting the 
topics of stress, depression and sleep.
The mechanisms of propagation of depressive disorder and related sleep 
disturbances remain unclear. Studying sleep in depressed adolescents can provide 
insight into the sleep structure changes common for early-onset depression. 
Genetic mechanisms that can predispose to depression and/or sleep problems can 
be investigated using large-scale birth cohort studies, which start during pregnancy 
and follow children through adolescence and beyond. In-depth mechanistic 
studies require, however, the use of experimental animals. Among animal models 
of early life stress, models based on the manipulation of mother-infant interaction, 
namely cross-fostering models (Barbazanges et al., 1996; Meaney & Szyf, 2005), are 
the less studied in the context of depressive-like behaviour and sleep alterations. 
Yet, they can be an invaluable tool in understanding the molecular mechanisms 
underlying	the	effect	of	early	life	stress	and	relationship	between	depression	and	
sleep disturbances. 
32. Review of the literature
2.1. Interconnection between depression and sleep disorders
2.1.1 Sleep: physiology, regulation and development
Sleep. Sleep is a reversible behavioural state of reduced responsiveness, 
which	 fulfils	some	universal,	but	yet	unknown,	vital	 function	 (Cirelli	&	Tononi,	
2008). Sleep occurs in repeating periods, during which the body alternates 
between	two	different	types	of	sleep:	rapid	eye	movement	(REM)	and	non-rapid	
eye movement (NREM) sleep (Hobson, 2005). NREM sleep is characterized by 
slow frequency and high amplitude waves in the electroencephalogram (EEG) 
(Figure 1). In humans, the NREM sleep can be further divided into three stages 
(N1, N2 and N3) distinguished by the amplitude of slow wave oscillations. N1 is 
the lightest stage of sleep, which is characterized by lowering EEG frequency and 
muscle tone, measured by electromyography (EMG). N2 stage is characterized by 
slow brain waves with occasional bursts of rapid waves (sleep spindles, 11-16 Hz). 
N3 stage is the deepest sleep stage, characterized by slow-wave activity (0.5-4.5 
Hz) of high amplitude (>75µV). Usually sleep stages alternate during the night 
within cycles of approximately 1.5-2 h. Sleep is entered through N1 and N2 stages 
and progresses to the deepest stage N3, which is also referred as slow-wave sleep 
(SWS). The cycle usually ends with REM sleep episode. REM sleep is characterized 
by high frequency and low amplitude waves in EEG, abolished muscle tone, and 
rapid eye movements, which can be detected by electrooculography (EOG). The 
deepest	NREM	stages	tend	to	predominate	during	the	first	sleep	cycles,	when	the	
sleep pressure is high, and decrease towards the morning, while REM sleep and 
light stages of NREM mostly predominate during the second part of the night. The 
total length of sleeping bout is about 6-8h, although the total duration of sleep per 
day can vary considerably between individuals.
Although human subjects are widely used in studies on sleep and sleep 
disorders, animal models provide an invaluable tool for research aimed at 
understanding the physiology of sleep and the underlying mechanisms of sleep 
4disorders. While laboratory rodents (rats and mice) are the most commonly used 
animal	models	 in	 sleep	 research,	 the	 differences	 in	 their	 sleep	 as	 compared	 to	
humans must be considered. Human sleep is consolidated usually to one main 
sleep phase, taking place during the dark period of the day. In contrast, rats are 
polyphasic animals, and their NREM–REM sleep cycles are relatively short (about 
10-14 mins) and occur periodically throughout the day, although predominantly 
during the light phase of the day (Toth & Bhargava, 2013). In spite of these 
differences,	 the	EEG	pattern	during	sleep	 (Figure	 1)	and	general	mechanisms	of	
sleep regulation are remarkably similar between rat and human (Borbely, 1982; 
Vyazovskiy & Tobler, 2005).
Figure 1. EEG, EMG and EOG patterns in humans and rats during wakefulness and sleep. 
EEG: electroencephalogram, EMG: electromyogram, EOG: electrooculogram, REM: rapid 
eye movement sleep, NREM: non-rapid eye movement sleep, N1-3: NREM sleep stages 1-3.
Sleep regulation. In spite of sleep being a behavioural state of quietness, it is 
an actively regulated process, not simply the passive result of diminished waking. 
According to the two-process model of sleep regulation, sleep is regulated by two 
interacting components: the homeostatic (Process S) and the circadian (Process C) 
(Borbely, 1982). The original version of this sleep regulation model was established 
to	account	for	sleep	regulation	in	humans	(Borbely,	1982)	and	was	later	verified	in	
rodents (Tobler et al., 1992). 
5The C process regulates the daily rhythms of the body and brain. Circadian 
patterns of activity are found in cells throughout the body, but the main circadian 
pacemaker is located in the suprachiasmatic nucleus of the hypothalamus (Moore, 
2007). This nucleus provides an oscillatory pattern of activity which controls the 
timing of the sleep-wake cycle and coordinates it with circadian rhythms in other 
brain areas and tissues.
The homeostatic component (Process S) of sleep regulation is dependent 
on the duration of preceding wake period. The homeostatic sleep pressure rises 
during waking and results in sleep. Recently it has been shown that not only the 
duration	of	preceding	wakefulness	is	affecting	the	homeostatic	component	of	sleep	
regulation, but also the type and amount of activity during waking (Hanlon et al., 
2009; Huber et al., 2007).
One of the principal physiological marker of sleep homeostasis (Process S) 
is	the	NREM	sleep	slow-wave	activity	(SWA,	defined	as	spectral	power	in	the	0.5-
4.5 Hz band) (Borbely & Achermann, 1999). SWA power increases progressively 
in the course of wakefulness (Borbely et al., 1981), and gradually reduces during 
sleep, including naps (Borbely & Achermann, 1999). In both humans and rats, 
the highest SWA is observed at the beginning of the resting phase and it declines 
towards its end (Dijk, 2009; Franken et al., 1991b). Thus, SWA is considered as a 
reliable indicator of sleep pressure and may be linked to the restorative function of 
sleep (Dijk, 2009).
Sleep across development. The amount of sleep and sleep characteristics 
change throughout the life span. The average sleep duration in adult humans 
varies between 6 to 9 h, while sleep length in infants is up to 16-17 h per day. 
Major	changes	occur	in	the	sleep-wake	pattern	across	the	first	year	of	life	when	
sleep changes from multiphasic to consolidated nocturnal uninterrupted sleep 
(Henderson	et	al.,	2011).	Sleep	structure	undergoes	significant	changes	as	well.	
The proportion of active sleep (analogous of REM sleep in adults) is high after 
birth and gradually declines with age (reaching an approximate adult value of 
25%	at	the	age	of	6	months)	and	proportion	of	quiet	sleep	(analogous	of	NREM	
sleep in adults) increases (de Weerd & van den Bossche, 2003; Mirmiran et al., 
2003). Hence, REM sleep is believed to be important for the brain maturation 
during early postnatal life (Marks et al., 1995). 
6Another	 significant	 developmental	 change	 in	 sleep	 occurs	 during	
adolescence,	when	sleep	and	its	regulation	is	undergoing	significant	maturational	
changes (Brand & Kirov, 2011; Colrain & Baker, 2011; Hagenauer et al., 2009). The 
most	remarkable	change	is	the	reduction	in	the	amount	of	SWS	(by	up	to	40%)	
and	SWA	(by	up	to	60%)	 (Baker	et	al.,	 2011;	Buchmann	et	al.,	 2011;	Campbell	&	
Feinberg, 2009; Colrain & Baker, 2011; Feinberg et al., 2006; Jenni & Carskadon, 
2004). Beside changes in sleep, the major maturational changes occur in brain 
neuronal networks, so called synaptic pruning (Hagenauer et al., 2009). Sleep, and 
particularly SWA, are closely interconnected with these changes and the observed 
decline in SWA during adolescence can represent a reduction in synaptic density 
occurring at this period of life (Feinberg & Campbell, 2010; Huttenlocher, 1979).
As	in	humans,	the	EEG	in	new-born	rats	is	undifferentiated	and	EEG	power	
gradually increases during early postnatal life. Sleep staging is usually based on 
behavioural	criteria,	defining	active	and	quiet	sleep	 (Frank	&	Heller,	 1997).	The	
adult features for each sleep stage are established around 3-4 weeks after birth. 
EEG maturation during adolescence in rats, as well as in humans, involves a decline 
in the SWA range (Mendelson & Bergmann, 1999).
2.1.2 Major depressive disorder
The incidence of depression is relatively low before puberty, but rises 
dramatically from the early teens with a preponderance among girls (Costello et 
al., 2003). According to epidemiological research, the incidence of MDD increases 
rapidly across adolescence (Burke et al., 1990; Newman et al., 1996; Oldehinkel et 
al.,	1999)	and	its	prevalence	ranges	from	5	to	12%	(Haarasilta	et	al.,	2001;	Hankin	et	
al., 1998; Lewinsohn et al., 1994; Oldehinkel et al., 1999). In a recent meta-analysis 
the	prevalence	of	MDD	was	estimated	as	 5.7%	among	 13-18-	year	old	 teenagers	
with a female to male ratio of 1.3:1 (Costello et al., 2006). Moreover, depression 
during adolescence frequently recurs or persists into adulthood, being a major 
contributing factor to health-related disability of young adults (Newman et al., 
1996; Pape et al., 2012; Pine et al., 1999; Sagatun et al., 2016). After adolescence 
and throughout adulthood, the gender divergence in depressed mood continues 
with adult women being twice as likely as men to experience depression (Nolen-
Hoeksema, 2001).
7MDD in adulthood is characterized by depressed mood and loss of interest 
or pleasure in daily activities that is present across most of the situations for more 
than	 two	weeks,	and	 it	 is	usually	accompanied	by	five	or	more	of	 the	 following	
symptoms: depressed mood, markedly diminished interest or pleasure in activities 
previously	 found	 pleasurable,	 significant	 weight	 change	 (5%)	 or	 change	 in	
appetite, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue 
or loss of energy, feelings of guilt or worthlessness, reduced concentration, and 
thoughts of death or suicide (American Psychiatric Association. Diagnostic and 
Statistical Manual of Mental Disorders, 2013). The above-mentioned symptoms 
cause	 clinically	 significant	 distress	 and	 impairment	 in	 social,	 occupational,	 or	
other important areas of life.
MDD in adolescence is diagnosed by the same set of symptoms as in 
adults, besides two exceptions (American Psychiatric Association. Diagnostic and 
Statistical Manual of Mental Disorders, 2013). First, depressed mood in children 
and adolescents can be substituted by irritability, and second, the duration for 
dysthymic disorder is one instead of two years. The clinical syndrome of depression 
is remarkably similar among children, adolescents, and adults. However, there are 
some	minor	developmental	differences	in	the	phenomenology	of	depression	(Rao	
& Chen, 2009; Weiss & Garber, 2003).
Understanding	 the	 pathophysiology	 of	 MDD	 is	 a	 challenging	 scientific	
problem and despite numerous studies, it still remains unclear (Brigitta, 2002; 
Hasler, 2010; Krishnan & Nestler, 2008). A few key factors in development 
of depressive disorder have given the foundation for basic theories of MDD 
pathophysiology.
Genetic theory. From early adolescence through adulthood women have 
a twofold higher risk of MDD as compared to men (Nolen-Hoeksema, 2001; 
Van de Velde et al., 2010). The neurobiological basis for this increased risk is 
unknown,	 and	 could	 be	 related	 to	 gender	 differences	 in	 hormonal	 or	 stress	
response systems, or to sexual dimorphism in brain areas involved in depression 
pathophysiology (Nestler et al., 2002; Nolen-Hoeksema, 2001). In a large twin 
study of children and adolescents it has been shown that postmenarcheal 
adolescent girls had elevated heritability for depressive disorders compared with 
boys	or	premenarcheal	adolescent	girls	(Silberg	et	al.,	1999).	This	finding	made	
8the authors to conclude that in adolescent girls, increased risk for depressive 
disorder is explained by an emerging genetic liability for depression combined 
with an increase in stressful life events. Family, twin, and adoption studies 
provide very solid and consistent evidence that MDD is a familial disorder and 
that this familiarity is mostly due to genetic factors (Sullivan et al., 2000). The 
influence	of	genetic	factors	is	accounted	for	30-40%,	the	remaining	60-70%	of	the	
variance in MDD vulnerability is explained by non-genetic factors, which usually 
are	individual-specific	environmental	effects,	such	as	adverse	childhood	events	
or other lifetime trauma and ongoing or recent stress. Several candidate genes 
have been extensively studied regarding their association with MDD, including 
serotonin transporter (5HTT/SLC6A4), serotonin receptor 2A (HTR2A), brain-
derived neurotrophic factor (BDNF) and tryptophan hydroxylase (TPH2)	(Lohoff,	
2010). The results suggest that, as in other complex psychiatric disorders, there 
is no universal susceptibility gene for MDD, but rather multiple genes with small 
effect	sizes	contribute	to	the	emergence	of	depression.	
Stress hormone theory. There is convergent evidence that the hypothalamic-
pituitary-adrenal (HPA) stress system plays a major role in the pathogenesis of 
certain types of depression (Pariante & Lightman, 2008). The HPA axis is one of 
the major neuroendocrine systems that is responsible for adaptation to changing 
demands of the environment and thereby contributes to the maintenance 
of	 different	 bodily	 functions	 (McEwen,	 2004).	 Hyperactivity	 of	 HPA	 system	
during MDD contributes to a range of physical long-term consequences of 
depression, such as coronary heart disease, type II diabetes, and osteoporosis 
(Gold & Chrousos, 1999). The role of altered stress hormone secretion (cortisol; 
a glucocorticoid) in depression vulnerability is particularly important in the 
mechanisms of childhood adverse experience (Heim et al., 2008). Moreover, 
epigenetic regulation of the glucocorticoid receptors is associated with early life 
adverse experience, as evidenced by both human and animal research (McGowan 
et al., 2009; Weaver et al., 2004). Environmental programming of gene expression 
through epigenetic regulation represents one possible mechanism that links 
early life stress to abnormal HPA axis function and increased risk of psychiatric 
diseases in adulthood.
9Monoamine-deficiency theory. According to this theory, the pathophysiological 
basis	of	depression	is	a	consequence	of	insufficient	amount	of	the	neurotransmitters	
serotonin, norepinephrine or dopamine in the central nervous system. The 
monoaminergic neurons are located in the midbrain and brainstem nuclei and 
send projections to large areas of the entire brain, particularly to the cortex. 
Monoamine theory of depression derives from the clinical observations that 
enhancing	of	serotonin	and	noradrenaline	transmission	have	antidepressant	effect	
(Prins et al., 2011). Experimental depletion of the serotonin leads to development of 
depressive symptoms in subjects at increased risk of depression (Neumeister et al., 
2004). Almost all established antidepressants target the monoamine systems: they 
amplify serotonin or norepinephrine signalling by inhibiting their catabolism or 
reuptake at the synaptic cleft (Mann, 2005). The several classes of antidepressant 
drugs include: selective serotonin reuptake inhibitors (SSRIs), norepinephrine-
reuptake inhibitors, and dual-action agents that inhibit uptake of serotonin and 
norepinephrine.	For	long	time	the	monoamine-deficiency	theory	was	considered	to	
be the most clinically relevant neurobiological theory of depression. However, there 
are several limitations in this theory. There are cases of full or partial resistance to 
the monoamine-based drugs, which suggests that dysfunctions of monoaminergic 
neurotransmitter	systems	found	in	MDD	can	be	secondary	to	effects	of	other,	more	
primary abnormalities (Massart et al., 2012). Moreover, therapeutic responses 
with antidepressants can only be achieved after at least 2–3 weeks of treatment, 
whereas antidepressants alter synaptic monoamine levels within hours (Frazer & 
Benmansour, 2002) .
Inflammation theory.	 Recently,	 the	 role	 of	 inflammation	 in	 depression	
development has been extensively investigated (Miller & Raison, 2016). Sickness 
behaviour shares many symptoms with depressive disorder, including fatigue, 
anhedonia, psychomotor retardation, and cognitive impairment. Patients with 
MDD	exhibit	all	principal	features	of	an	inflammatory	response,	such	as	increased	
expression	 of	 pro-inflammatory	 cytokines	 (interleukin	 (IL)	 -	 1β,	 2,	 6,	 8,	 12,	
interferon	 γ,	 tumor	 necrosis	 factor	 (TNF)-α)	 and	 their	 receptors	 and	 increased	
levels of acute-phase reactants, chemokines and soluble adhesion molecules in 
peripheral	blood	and	cerebrospinal	fluid	(Miller	et	al.,	2009;	Zorrilla	et	al.,	2001).	In	
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rodents, administration of cytokines induces depressive-like symptoms, including 
anhedonia and anxiety (Anisman & Merali, 2002).
Circadian disruption theory. In depression, multiple circadian rhythms 
are disturbed, including the rhythmic secretion of many hormones, body 
temperature	circadian	profile,	 as	well	 as	 sleep-wake	cycle	 (Germain	&	Kupfer,	
2008;	Hasler	&	Northoff,	2011).	Among	the	most	common	circadian	disruptions	
that MDD patients experience are: shortened latency of REM sleep, early 
morning awakenings, early morning rise of adrenocorticotropic hormone 
(ACTH; stimulates cortisol synthesis in the adrenal glands) and night peaks 
of prolactin and growth hormone. All these abnormalities are the symptoms 
of a phase advance circadian disorder. The fact that in depression a variety of 
circadian functions are disturbed led to a speculation that the association with 
depression is due to a disruption in central circadian clock function and not to an 
alteration	in	one	specific	rhythm	(Turek,	2007).	
Neurotrophin deficiency theory. Neuronal atrophy in the hippocampus and 
other forebrain regions, as well as reduced neurotrophic factor expression observed 
in	depressed	patients,	have	supported	the	neurotrophin	deficiency	hypothesis	of	
depression (Castren et al., 2007; Duman & Monteggia, 2006). Several neurotrophic 
factors are associated with depression or antidepressant action, and the most 
studied of them is BDNF (Castren & Rantamaki, 2010). More detailed description 
of this theory will be provided in the section 1.2.2 Role of BDNF in depression after 
giving basic information about BDNF.
Additional MDD theories include altered glutamatergic and reduced 
GABAergic neurotransmission, impaired endogenous opioid function (Belmaker 
& Agam, 2008), glial-based synaptic dysfunction (Rial et al., 2016) and vitamin D 
deficiency	(Milaneschi	et	al.,	2014).
Integrated model of current MDD hypotheses. The existence of so 
many theories of depression, which are supported by solid evidences from 
epidemiological,	clinical	and	experimental	studies	clearly	argue	against	a	“unified	
hypothesis of depression” and suggest that depression is clinically and etiologically 
heterogeneous disorder. Integration between these numerous hypotheses of 
depression pathophysiology may better explain the biology of depression and its 
heterogeneous clinical presentations. 
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Hyperactivation	 of	 HPA	 axis,	 which	 is	 a	 common	 finding	 in	 patients	
with MDD results in high level of the stress hormone cortisol, which may 
cause impairment in neuroplasticity and cellular resistance (Manji et al., 
2003).	Indeed,	glucocorticoids	are	well	established	to	affect	synaptic	plasticity	
and to contribute for synaptic atrophy in several brain regions (Sousa et al., 
2008). Moreover, an imbalance between glucocorticoid and mineral corticoid 
receptors in depression along with high-density glucocorticoid receptors may 
also contribute to the hippocampus’ susceptibility to neuronal damage (de 
Kloet et al., 2007). Furthermore, HPA axis overactivity, in conjunction with 
amygdala activation in depression, leads to increased sympathetic tone, which 
promotes	 the	 release	 of	 pro-inflammatory	 cytokines	 (TNF-α,	 IL-1,	 6)	 from	
macrophages (Maletic et al., 2007) (Figure 2). On the one hand, this increase 
in	 pro-inflammatory	 cytokines	 has	 been	 associated	with	 loss	 of	 insulin	 and	
glucocorticoid receptors sensitivity, which further aggravate metabolic and 
neuroendocrine	abnormalities.	On	the	other	hand,	pro-inflammatory	cytokines	
may also diminish neurotrophic support and monoamine neurotransmission 
(including serotonin and dopamine) that can lead to further neuronal 
apoptosis and glial damage. Stress, depression and immune dysregulation 
lead to activation of microglia that then contribute to the existing immune 
disruption	by	additional	release	of	pro-inflammatory	cytokines	(Maletic	et	al.,	
2007).	Pro-inflammatory	cytokines,	such	as	TNF-α	and	IL-1β	has	been	shown	
to	decrease	neurogenesis	 in	selected	brain	areas,	possibly	by	affecting	BDNF 
expression in neurons (Audet & Anisman, 2013; Maes et al., 2009). In addition 
to	cytokines,	glucocorticoids	can	also	affect	BDNF	transcription	by	interfering	
with its transcriptional mechanisms (e.g. by decreasing cyclic-AMP-response-
element-binding protein (CREB) activity) (Krishnan & Nestler, 2008).
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Figure 2.	 Simplified	scheme	of	 interaction	between	different	hypotheses	of	depression.	
Hyperactivation	of	HPA	axis	leads	to	an	increased	release	of	CRH	and	pro-inflammatory	
cytokines (TNF, IL-1, 6), and, in conjunction with amygdala activation, causes increased 
sympathetic tone. Sympathetic overactivity contributes to immune activation and release 
of	inflammatory	cytokines.	Inflammatory	cytokines	further	interfere	with	monoaminergic	
and neurotrophic signalling and activate microglia. HPA: hypothalamic–pituitary–adrenal 
axis, A: amygdala, Hip: hippocampus, Hyp: hypothalamus, ACTH: adrenocorticotropic 
hormone, CRH: corticotrophin releasing hormone, BDNF: brain-derived neurotrophic 
factor, 5-HT: serotonin; DA: dopamine, NA: noradrenaline, MF: macrophage, TNF: tumor 
necrosis factor, IL: interleukin.
2.1.3 Sleep in major depressive disorder
Depressive disorder is usually characterized by subjective sleep disturbances 
(Nutt et al., 2008; Thase, 2006), which is one of the diagnostic symptoms of 
depression.		Multiple	disturbances	in	sleep	structure	are	evident	in	about	45%	of	
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depressed	outpatients	and	80%	of	more	severely	depressed	inpatients	(Tsuno	et	
al., 2005). Moreover, people with persistent sleep problems have elevated risk of 
developing MDD within one year (Breslau et al., 1996; Paunio et al., 2015). The 
relationship between sleep and depression is bidirectional, complex and has 
remained poorly understood.
The whole range of sleep problems observed in depressed adults (Armitage, 
2007) can be divided in three groups (Steiger & Kimura, 2010): impaired sleep 
continuity (prolonged sleep latency, increased number of night awakenings); rapid 
eye movement (REM) sleep disinhibition (shortened REM sleep latency, elevated 
REM sleep frequency and duration); and NREM sleep changes (decreased NREM 
sleep duration and reduced SWA). The majority of depressed patients complain 
about	 insomnia	 (~80%),	while	hypersomnia	 is	observed	 in	some	cases	 (15-35%)	
(Steiger & Kimura, 2010).
Different	REM	and	NREM	sleep	parameters	have	been	previously	shown	to	
correlate with the severity of depressive symptoms in adults (Perlis et al., 1997). The 
sleep parameters include SWA, increased relative amount of N1 stage, increased 
REM	 activity	 and	 efficiency,	 increased	 sleep	 latency,	 and	 depressive	 symptoms	
included loss of appetite/weight, decreased libido, sleep problems, feelings of 
dissatisfaction and failure.  
As well as in adulthood, sleep disturbance in adolescence is one of the key 
symptoms of depressive disorder. Moreover, the prevalence of insomnia is rising 
from	childhood	to	adolescence	reaching	about	11-13%	(Hysing	et	al.,	2013;	Johnson	
et al., 2006). Depressed adolescents often complain about their sleep (Liu et al., 
2007; Urrila et al., 2012), but the results from objective polysomnographic studies 
show	different	findings.	Some	studies	in	depressed	adolescents	have	demonstrated	
sleep changes, which are common for depressed adults, such as increased sleep 
onset latency, REM sleep amount and density, decreased REM sleep latency and 
sleep	 efficiency	 (Augustinavicius	 et	 al.,	 2014;	 Kutcher	 et	 al.,	 1992;	 Lopez	 et	 al.,	
2010; Lopez et al., 2012; Rao et al., 2009; Robert et al., 2006). Few studies have also 
reported	lower	SWA	in	the	first	NREM	sleep	episode	and	its	irregular	dissipation	
through the night in depressed adolescents compared to healthy ones (Armitage et 
al., 2001; Lopez et al., 2012). Recently, it has also been shown that the topographical 
pattern of SWA distribution in depressed adolescents is characterized by increased 
14
SWA over the frontal cortex compared to healthy controls (Tesler et al., 2016). 
Other studies have failed to demonstrate abnormalities in sleep architecture (Dahl 
et	al.,	1990;	Goetz	et	al.,	1987;	Khan	&	Todd,	1990).	The	difference	in	findings	can	
be explained by e.g. the heterogeneity of studied samples in terms of gender, age/
pubertal status, and the variable clinical features/symptoms of depression.
Sleep abnormalities observed in depression point to a disruption in both 
homeostatic and circadian components of sleep regulation. Decreased REM latency, 
increase in waking time and N1 stage, and waking up early could be associated to 
a circadian disturbance resulting in earlier onset of sleep rhythms. Whether the 
circadian rhythm disruption is a cause or a consequence of depression is a subject 
of many studies focusing on genetic control of the mammalian clock (Germain & 
Kupfer, 2008).
	The	homeostatic	process	deficiency	hypothesis	suggests	that	depression	is	
accompanied by an attenuated build-up of sleep pressure, and S process does not 
rise to its usual level in the course of waking (Borbely, 1987; Borbely & Wirz-Justice, 
1982). This leads to subsequent reduction in SWA power during sleep. This theory 
is supported by studies that demonstrate reduced SWA in both adult (Armitage, 
2007;	Borbely	et	al.,	1984;	Hoffmann	et	al.,	2000)	and	adolescent	(Armitage	et	al.,	
2001; Lopez et al., 2012) depressed patients. Diminished SWA in sleep was also 
observed in animal models of depression (Savelyev et al., 2012; Touma et al., 2009). 
Moreover,	SWA	distribution	across	the	first	two	NREM	sleep	episodes	(known	as	
delta sleep ratio) has been previously linked to clinical outcome and responsiveness 
to depression treatment in adult patients with MDD (Ehlers et al., 1996; Kupfer et 
al., 1990): a better response to therapy was observed in subjects with a higher delta 
sleep ratio.
Suggestion of participation of both S and C processes in depression rises 
from observations that total or partial (in the second half of the night) sleep 
deprivation (SD) in MDD patients improves mood during the next day (Giedke 
& Schwarzler, 2002). SD rapidly improves mood in depressed patients, but a 
subsequent sleep/nap commonly reverses this improvement. Mood in many MDD 
patients is also worse in the morning and gradually improves during the day, and 
then reverses back to depression in the course of sleep. One of the explanations for 
the	therapeutic	effect	of	SD	is	that	it	changes	the	phase-angle	between	advanced	
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circadian pacemaker and sleep need (Wirz-Justice & Van den Hoofdakker, 1999). 
According	to	the	homeostatic	S	process	deficiency	theory,	SD	is	helpful	because	
the level of sleep pressure is transiently increased to normal, and relapse occurs 
after recovery sleep due to the return to low levels of sleep pressure. Moreover, 
according	to	recent	research,	 the	mechanism	of	antidepressant	effect	of	SD	can	
be associated with rapid increase in BDNF serum levels on the day following the 
partial or total SD (Gorgulu & Caliyurt, 2009; Schmitt et al., 2016). However, the 
above mentioned possible mechanisms are not mutually exclusive. 
Thus, depression and sleep disturbances are tightly interconnected. The 
existence of common subtracts for sleep and mood regulation could potentially 
explain the bidirectional association between depression and sleep disorders.
2.2. BDNF: a possible bridge between major depression and 
sleep disorders
2.2.1 Characteristics of BDNF
BDNF is one of the most widely distributed neurotrophins of the central 
nervous system, which is abundantly expressed in the developing and adult 
mammalian	brain.	In	immature	neurons,	BDNF	is	involved	in	growth,	differentiation,	
maturation and survival while in mature neurons it plays an important role in 
synaptic plasticity, augmentation of neurotransmission and regulation of receptor 
sensitivity (Calabrese et al., 2009; Gonzalez et al., 2016; Numakawa et al., 2010). 
BDNF	mediates	 its	 biological	 effects	 via	 two	 types	 of	 receptors:	 TrkB	 and	 p75.	
Recent studies indicate that binding of mature BDNF protein with TrkB receptors 
promotes neuronal survival, enables long-term potentiation and enhances 
synaptic plasticity, whereas binding of precursor (pro-BDNF) with p75 receptors 
has	biological	effects	oppose	to	those	of	mature	BDNF	(Lu	et	al.,	2005).	Thus,	the	
balance between pro- and mature BDNF on the one hand, and between the p75 and 
TrkB receptors on the other, is of critical importance in determining the functional 
characteristics of the BDNF signal.
Gene structure and regulation. The BDNF protein is coded by the BDNF gene. 
Rodent and human BDNF genes have multiple untranslated 5′-exons (I–IX). Every 
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single 5′-exon	is	normally	spliced	to	one	coding	exon	with	two	different	3′-UTRs 
(untranslated region), resulting in numerous possible BDNF transcripts variants. 
Each exon has its own promoter, which is located upstream of corresponding 5′ 
-noncoding	exon	allowing	time-	and	brain	area-specific	control	of	BDNF expression 
in an activity-dependent manner (Aid et al., 2007; Chen & Chen, 2017; Karpova, 
2014).	 This	 provides	 adequate	 adaptive	 responses	 to	 different	 environmental	
factors, such as physical exercise, learning, environmental enrichment or stress 
(Calabrese et al., 2009). Interestingly, all transcripts are eventually translated into 
an identical protein (Aid et al., 2007; Pruunsild et al., 2007). 
The regulation of BDNF expression, depending on environmental 
conditions, is mediated through epigenetic mechanisms. Epigenetic regulation is 
a recently emerged frontier in genetic science, which has been shown to be able 
to alter DNA accessibility and chromatin structure, thereby regulating patterns 
of gene expression without changing the DNA sequence (Bird, 2007). Epigenetic 
mechanisms of regulation include  methylation, acetylation, phosphorylation, 
ubiquitylation, sumoylation, and microRNA control (Weinhold, 2006). In activity 
dependent BDNF regulation, the most frequently studied mechanisms have been 
DNA	methylation	and	translational	histone	modifications.	
DNA methylation is an essential epigenetic mechanism for gene silencing 
(Figure 3). DNA methyltransferases (DNMT) catalyze the transfer of a methyl 
group from a donor S-adenosylmethionine to a cytosine at position C5, resulting 
in a new nucleotide 5-methylcytosine (5-mC), generally in the context of CpG 
dinucleotides (Karpova, 2014). CpG dinucleotides tend to cluster in CpG islands 
(CG-rich DNA regions). Methylated CpG islands are typically associated with 
silent DNA whereas unmethylated CpG islands are targets for transcription factors. 
Evidence	 for	existence	of	a	 specific	DNA	demethylase	 that	may	directly	 remove	
the methyl group from 5-mC is controversial, but studies suggest that it can be 
done with the help of DNA glycosylases through a base excision-repair pathway 
(Bhattacharya et al., 1999; Zhu, 2009).
In	addition	to	changes	in	DNA-methylation,	post-translational	modifications	
of histones are involved in  modulation of BDNF gene expression (Chen & Chen, 
2017;	Karpova,	 2014;	Mitchelmore	&	Gede,	 2014).	One	of	 these	modifications	 is	
histone	acetylation,	which	influences	chromatin	structure.	Histone	acetylation	is	
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regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs) 
(Figure 3). It should be mentioned that DNA is wrapped around nucleosomes, 
which each consist of 8 histone protein cores that are highly basic. HATs catalyze 
the lysine acetylation that neutralizes the lysine׳s positive charge and weakens 
the interactions between the negative DNA backbone and the histone, making 
the DNA more accessible for the transcription machinery. In contrast, HDACs 
mediate the removal of the acetylation mark, resulting in the formation of DNA 
that	 is	 less	 accessible	 to	 transcription	 factors.	 Another	 mechanism	 affecting	
gene transcription is histone methylation/demethylation, which is regulated by 
histone methyltransferases (HMTs) and demethylases (HDMTs), respectively. For 
example, methylation at lysine (K) 27 on histone H3 (H3K27) is usually associated 
with transcriptional repression (Tsankova et al., 2007). Adverse environmental 
conditions have been shown to reduce BDNF expression through repressive 
histone H3 methylation at the BDNF promoters in rodent brains (Karpova et al., 
2010; Onishchenko et al., 2008), whereas positive experience has been shown to 
increase BDNF expression	through	histone	modifications	(Kuzumaki	et	al.,	2011).
Figure 3.	A	scheme	of	reversible	epigenetic	modifications	involved	in	the	regulation	of	BDNF 
gene transcription. Acetylation (Ac) of histones leads to activation, whereas methylation (Me) 
leads to inactivation of gene expression. Methylation (Me) of cytosines at CpG dinucleotides 
in DNA also leads to inactivation of gene expression. DNMT: DNA methyltransferase; HAT: 
histone acetyltransferase; HDAC: histone deacetylases; HMT: histone methyltransferase; 
HDMT:	histone	demethylase.	Modified	from	(Mitchelmore	&	Gede,	2014).
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BDNF gene polymorphisms. Among all BDNF gene polymorphisms, the most 
widely studied is Val66Met polymorphism, a naturally occurring variation in the 
human BDNF gene, resulting in a valine (Val) to methionine (Met) substitution at 
codon	66.	This	substitution	does	not	affect	mature	BDNF	protein	function,	but	it	
has	been	shown	to	alter	the	intracellular	trafficking	and	packaging	of	pro-BDNF	
(Egan et al., 2003). This in turn leads to the reduction of activity-dependent release 
of the mature peptide (Egan et al., 2003). It is still unclear what the consequences 
of the Val66Met polymorphism are on brain function, as both alleles have been 
associated	with	different	disease	processes	including	substance-related	disorders,	
schizophrenia, and eating disorders (Gratacos et al., 2007). It is also known that 
BDNF	allele	 frequencies	differ	by	ethnicity	with	higher	prevalence	of	Met	allele	
in	Asian	population	 (40-50%)	compared	 to	Caucasians	 (25-32%),	where	Val/Val	
genotype is the most prevalent (Pivac et al., 2009).
2.2.2 Role of BDNF in depression
BDNF hypothesis of MDD originates from the observations that acute and 
chronic stress in humans decrease endogenous neurotrophin levels and can lead 
to atrophy and cell loss in limbic brain structures (especially hippocampus), the 
structures involved in mood regulation (Duman, 2004; Duman & Monteggia, 
2006).	 In	 contrast	 to	 the	 effects	 of	 stress,	 antidepressant	 treatment	 increases	
the expression of neurotrophic factors and increases neurogenesis (Castren & 
Rantamaki, 2010; Lee & Kim, 2010). Thus, depression is considered to be a result 
of inability of the brain to make appropriate adaptive responses to environmental 
stimuli as a consequence of impaired synaptic plasticity and structural plasticity, 
mediated by neurotrophins.
BDNF in depression. In experimental studies using animal models of 
depression,	 it	 has	 been	 shown	 that	different	 types	of	 stressors	 (immobilization	
stress, foot shocks, social defeat, and early maternal deprivation), as well as 
exogenous corticosterone administration, reduce hippocampal BDNF expression 
(Roceri et al., 2002; Schaaf et al., 1998; Smith et al., 1995; Ueyama et al., 1997), 
whereas adrenalectomy increases the level of BDNF in the hippocampus, 
indicating that the regulation of hippocampal BDNF occurs partially through HPA 
axis (Chao et al., 1998). Similar observations were made in the frontal cortex, where 
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corticosterone administration decreased level of BDNF expression, while treatment 
with antidepressants returned its level to normal (Dwivedi et al., 2006). It should 
be noted that sole central reduction in BDNF level, observed in heterozygous 
BDNF	knockout	mice,	is	not	sufficient	to	produce	depressive-like	behaviour,	but	
rather, the reduction appears to increase susceptibility to stress: exposure of BDNF 
heterozygous knockout mice to stress induces depressive-like behaviour, as does 
the blockade of BDNF-TrkB signalling following stress (Duman et al., 2007).
The	 relevance	 of	 findings	 obtained	 in	 basic	 animal	 research	 studies	 has	
been	confirmed	by	findings	in	clinical	studies	on	depressed	patients.	Post-mortem	
studies demonstrate that levels of BDNF in the hippocampus or prefrontal 
cortex are decreased in depressed suicide subjects as compared to matched, non-
depressed controls (Dwivedi et al., 2003). Moreover, depressed individuals, who 
were treated with antidepressant drugs, had increased BDNF expression compared 
to medicine-free patients (Chen et al., 2001). Recent clinical studies on serum or 
plasma BDNF levels in patients with MDD demonstrated that medicine-free MDD 
patients have lower BDNF levels than healthy individuals (Gonul et al., 2005; Lee 
et al., 2007; Shimizu et al., 2003). Although blood platelets represent the main 
source of BDNF in serum (Chacon-Fernandez et al., 2016), BDNF can also, to some 
extent, cross the blood-brain barrier in both directions, indicating that circulating 
BDNF could partially originate from neurons of the brain (Pan et al., 1998; Poduslo 
&	Curran,	1996).	In	this	regard,	differences	in	BDNF	levels	in	plasma	may	represent	
the variable BDNF secretion in the human brain.
BDNF and antidepressant drug action. Delayed onset of action of conventionally 
used antidepressant drugs prompted the idea that other mechanisms, than just 
increase in monoamine levels, e.g. BDNF-mediated reorganization of neuronal 
networks, could be responsible for the antidepressant response.
Indeed, it has been shown in many studies that commonly used 
antidepressants increase BDNF mRNA and protein expression in the rodent brain, 
particularly in the hippocampus and cortical regions in a timeframe similar to the 
onset of the antidepressant-like response (Duman & Monteggia, 2006; Hajszan 
et al., 2005; Nibuya et al., 1995; Warner-Schmidt & Duman, 2006).  Moreover, the 
antidepressant	effects	of	BDNF	have	been	shown	to	be	mediated	by	TrkB	activation	
(Saarelainen et al., 2003). Direct infusion of BDNF protein into the midbrain or 
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hippocampus	also	led	to	an	antidepressant-like	effect	in	rodents	(Shirayama	et	al.,	
2002; Siuciak et al., 1997). 
Recently it has been suggested that one of the mechanism of antidepressant 
effect	of	BDNF	is	the	ability	to	reactivate	developmental-like	neuronal	plasticity	in	
the adult brain (Castren & Rantamaki, 2010). Previous work, using the monocular 
deprivation during early development, resulting in impaired vision of the 
deprived eye in adulthood, had shown that the impairment could be recovered 
during	 adulthood	 by	 chronic	 administration	 of	 fluoxetine	 (an	 antidepressant	
of the SSRI class) combined with simultaneous patching of the dominating eye 
(Maya-Vetencourt et al., 2008). It is known that activity-dependent reorganization 
of	 neuronal	 networks	 is	 efficient	 only	 during	 a	 critical	 period	 of	 postnatal	
development and it is greatly reduced after the end of this period. Thus, if the 
vision of deprived eye is not corrected during the critical period of development, 
it	 remains	 permanently	 impaired	 during	 adulthood.	 However,	 fluoxetine	
combined with rehabilitation was able to activate neuronal plasticity, leading to 
functional reorganization of neuronal networks even after the end of the critical 
developmental period. Moreover, during the treatment, BDNF levels increased in 
the visual cortex, and direct infusion of BDNF into the visual cortex mimicked the 
effects	of	fluoxetine	(Maya-Vetencourt	et	al.,	2008)	),	indicating	that	BDNF	may	be	
a	critical	mediator	of	the	antidepressant	drug	effect.
Thus, according to this theory conventionally used antidepressants might 
work	 similarly	 to	fluoxetine	and	 “open”	 sensitive	developmental-like	window	of	
BDNF-mediated plasticity in the brain, leading to the reorganization of neuronal 
networks and their better adjustment to environmental challenges. 
BDNF Val66Met polymorphism and depression. Number of studies have 
associated BDNF Val66Met polymorphism with increased susceptibility to 
neuropsychiatric disorders, including MDD and anxiety disorder (Autry & 
Monteggia, 2012; Neves-Pereira et al., 2002; Sen et al., 2003; Sklar et al., 2002). 
However, the risk allele for depression and depression-related traits has not been 
clearly	defined.	It	has	been	suggested	that	early	life	stress	coupled	with	presence	of	
Met allele may play a crucial role in increasing the susceptibility for MDD (Gatt et 
al., 2009). Met allele has been also associated with alterations in brain anatomy and 
memory, leading to impaired episodic memory and reduced hippocampal volume 
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(Hariri	et	al.,	2003;	Pezawas	et	al.,	2004),	findings	often	observed	in	subjects	with	
MDD. The association between BDNF Val66Met polymorphism and neuroticism, 
as a major risk factor for psychiatric disorders, including depression (Jylha et al., 
2009), has been studied, but the results are controversial (Huennerkopf et al., 2007; 
Itoh et al., 2004). Some studies indicate higher levels of neuroticism in Val allele 
homozygous individuals than in Met carriers, while others failed to show such 
association (Tochigi et al., 2006; Wray et al., 2008); one study found the association 
in females, but not in males (Itoh et al., 2004). Moreover, a link between BDNF 
allelic	variation	and	another	temperament	trait,	extraversion,	has	been	identified	
(Terracciano et al., 2010). Val allele has also been found associated with higher 
anxiety trait (Lang et al., 2005), which is a potent risk factor for the development 
of depression. Also, a family-based study showed that Val allele is associated with 
childhood-onset mood disorders (Strauss et al., 2005)
In an animal model of the Val66Met polymorphism, Met allele was associated 
with neuronal development defects that lead to reduced hippocampal volume. 
However, this structural change did not contribute to depression-like behaviour 
in rodents (Frielingsdorf et al., 2010). In another rodent study, it has been shown 
that Met/Met mice had increased anxiety-related behaviour, which could not be 
reversed	by	fluoxetine	treatment	(Chen	et	al.,	2006).
2.2.3 Role of BDNF in sleep regulation
BDNF has a particular role in sleep regulation, which has been shown in 
both experimental animal studies and clinical research (Cirelli, 2009; Faraguna et 
al., 2008; Giese et al., 2014b; Martinowich et al., 2011; Nishichi et al., 2013; Savelyev 
et al., 2012).  In rats, the expression of BDNF mRNA and protein levels are higher 
during spontaneous or prolonged wakefulness than during sleep (Cirelli & Tononi, 
2000a; Hairston et al., 2004). Moreover, there is a causal link between cortical 
BDNF expression and SWA in the following sleep episode: the higher the cortical 
expression of BDNF is during wakefulness, the larger is the increase in SWA during 
the subsequent sleep period (Faraguna et al., 2008). On the other hand, impaired 
secretion of BDNF protein or blocking its receptors leads to decrease in sleep 
duration	and	efficiency	 (Faraguna	et	 al.,	 2008;	Martinowich	et	 al.,	 2011).	 Short-
term	 SD	 (up	 to	 12h)	 significantly	 increases	BDNF expression in the cortex and 
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hippocampus (Cirelli & Tononi, 2000b; Fujihara et al., 2003), whereas prolonged 
sleep loss (for up to 7 days) led to smaller elevation in BDNF expression (Cirelli 
et	al.,	2006).	One	study	analysed	the	effect	of	SD	on	different	BDNF transcripts 
and found that activity-dependent BDNF transcripts BDNF1-4 and BDNF 9a are 
involved in sleep homeostasis (Martinowich et al., 2011). Moreover, disruption 
in activity-dependent BDNF4 transcription led to impaired sleep homeostasis 
and	short	sleep	duration	 	(Martinowich	et	al.,	2011).	These	findings	suggest	that	
BDNF	transcription	during	spontaneous	sleep-wake	cycle	can	be	exon-specific	and	
epigenetic mechanisms might play an important role in BDNF regulation of sleep 
homeostasis.  
In clinical studies, patients with symptoms of insomnia demonstrated 
decreased serum BDNF levels, and its level correlated with severity of insomnia 
(Giese et al., 2013; Giese et al., 2014b), while after therapeutic SD in MDD patients, 
fast increase in serum BDNF level was observed (Giese et al., 2014a). These 
contradictory	findings	can	be	explained	by	biphasic	model	of	stress,	and	therefore,	
different	response	in	BDNF	expression	to	chronic	vs.	acute	stress	(Schmitt	et	al.,	
2016).
Studies on the role of BDNF polymorphisms, particularly Val66Met, in sleep 
regulation are scarce. Val66Met polymorphism has been associated with sleep 
efficiency,	thus	Val	allele	homozygotes	individuals	have	been	shown	to	have	higher	
SWA in baseline sleep and post-sleep deprivation recovery sleep, than carriers of 
Met allele (Bachmann et al., 2012).Moreover, some changes in microarchitecture of 
sleep were observed  in Met carriers (Guindalini et al., 2014). 
2.3. Sleep and homeostatic plasticity
A large number of studies in humans and animals suggest that sleep is 
required for memory consolidation and learning, which are based on processes 
of long-term synaptic potentiation (LTP) and depression (LTD) (Rasch & Born, 
2013). In classical Hebbian plasticity, the process of presynaptically emerged action 
potential activating the postsynaptic neuron, strengthens the synapse and forms 
the neurophysiological mechanism for memory (Fox & Stryker, 2017). New synapses 
are formed and strengthened in the course of the learning process. However, 
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this cannot continue endlessly, a restriction mechanism is needed. Homeostatic 
plasticity	offers	such	mechanism(s).
The theory which links sleep with synaptic homeostasis (synaptic homeostasis 
hypothesis or SHY) was proposed by Tononi and Cirelli (Tononi & Cirelli, 2003, 
2006) in order to explain the fundamental function of sleep as restoration of 
synaptic homeostasis. According to SHY, wakefulness is accompanied by synaptic 
potentiation in a large fraction of cortical circuits, resulting in a LTP and a net 
increase	 in	 synaptic	weight.	 Rodent	 studies	 show	a	diffuse	 increase	 in	 synaptic	
density in animals exposed to enriched environments (Klintsova & Greenough, 
1999) and activation of LTP-related genes, including the BDNF, during spontaneous 
wakefulness (Cirelli & Tononi, 2000a). The amount of SWA during sleep is tied to 
the amount of synaptic potentiation that has occurred during previous wakefulness 
(Cirelli & Tononi, 2000b; Huber et al., 2004; Kelly & Deadwyler, 2003). This relation 
between synaptic potentiation and following SWA is proportional: the higher 
the amount of synaptic potentiation in cortical circuits during wakefulness, the 
higher the increase in SWA during subsequent sleep. Moreover, it has been shown 
that SWA increases locally in the brain areas which were involved in synaptic 
potentiation during wakefulness, and this increase correlates with post-sleep 
improvements in performance (Huber et al., 2004). Evidence for a relationship 
between synaptic density and SWA also comes from the developmental studies: 
both synaptic density and SWA reach their peak in adolescence, after which they 
gradually decline (Feinberg & Campbell, 2010; Feinberg et al., 2006; Feinberg et al., 
1990). 
Moreover, according to SHY, SWA is associated with generalized depression 
or downscaling of synaptic strength, i.e. proportional reduction in the strength of 
all synapses converging onto the same neuron (de Vivo et al., 2017; Tononi & Cirelli, 
2003, 2014). In other words, sleep in needed for weakening synapses through a 
process of downscaling or synaptic renormalization. Indirect evidences supporting 
this idea come from the experiments demonstrating a downregulation of LTP-
related genes (Cirelli & Tononi, 2000a) and upregulation of molecules implicated 
in depotentiation/depression during spontaneous sleep (Cirelli et al., 2004) 
indicating that sleep may be an unfavourable condition to synaptic potentiation. 
Two recent imaging studies of cortical dendrite spine morphology support the idea 
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that sleep may play an important role in downscaling the strength and number of 
synaptic connections (Maret et al., 2011; Yang & Gan, 2012). These studies showed 
that the ratio of spines eliminated versus those formed was greater after a period 
of sleep than a period of wakefulness. Authors of SHY also speculate that a process 
of generalized downscaling may not be compatible with wakefulness, while it 
would be ideally compatible with sleep, a state during which the brain is both 
spontaneously active and virtually disconnected from the environment; and the 
reduced activity of the noradrenergic system during sleep would ensure that only 
downscaling occurs, and not potentiation (Tononi & Cirelli, 2003).
SHY is consistent with other theories that propose a similar synaptic 
weakening	effect	of	sleep	(Crick	&	Mitchison,	1983;	Giuditta	et	al.,	1995).	A	number	
of studies in insects, rodents and humans provide evidences that are in line with 
SHY (Gilestro et al., 2009; Huber et al., 2004; Liu et al., 2010; Vyazovskiy et al., 
2008). However, this hypothesis also meets criticism since very little is known 
about the mechanisms that underlie the process of synapses weakening during 
sleep (Frank, 2012, 2013).
According to another view, homeostatic plasticity stabilizes neuronal 
excitability	and	maintains	the	so	called	neuronal	firing	rate	homeostasis	through	
mechanisms of intrinsic and synaptic plasticity (Turrigiano, 2011). Moreover, 
neuronal activity in neuronal circuits returns to baseline individual set point after 
periods	of	quietness	and	activity.	It	has	been	shown	that	the	firing	rate	homeostasis	
is	gated	by	sleep/wake	states,	and	that	sleep	inhibits	rather	than	promotes,	firing	
rate	 homeostasis.	 This	 idea	was	 prompted	 by	 the	 research	 studying	 the	 effects	
of	visual	deprivation	on	neuronal	firing	rates	 in	the	primary	visual	cortex	using	
monocular deprivation model (Hengen et al., 2016). It has been shown that in spite 
the	fact	that	monocular	deprivation	depressed	at	first	the	firing	rate	of	individual	
neurons	in	visual	cortex,	firing	rates	returned	precisely	to	the	neuron’s	individual	
baseline later during periods of active wake, but not during the sleep. Thus, this 
finding	suggests	that	the	relationships	between	sleep	and	homeostatic	plasticity	
are opposite to those that has been proposed in SHY. According to this model 
wakefulness but not sleep state enables the expression of homeostatic plasticity. 
Recently, another model was introduced, which suggests that sleep is 
needed	for	homogenization	of	the	firing	rate	distribution	through	cortical	neurons	
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(Levenstein et al., 2017; Watson et al., 2016). This model is based on a study using 
large-scale recordings to examine the activity of neurons in the frontal cortex of 
freely behaving rats (Watson et al., 2016). It has been shown that the distribution 
of	pyramidal	cell	firing	rates	was	wide	and	strongly	skewed	toward	high	firing	rates.	
Furthermore,	neurons	from	different	parts	of	this	distribution	were	differentially	
modulated	by	 sleep	stages:	NREM	sleep	 reduced	 the	activity	of	 high	firing	 rate	
neurons	 and	 tended	 to	 upregulate	 firing	 of	 slow-firing	 neurons,	 whereas	 REM	
sleep	reduced	firing	rates	across	the	entire	rate	spectrum.
All above mentioned theories have strong experimental support and whether 
they are describing the same phenomenon will be studied in future.
2.4. Adenosine: role in sleep regulation and depression
The idea that adenosine plays a role in sleep control came from the studies 
on systemic and central administrations of adenosine agonists and antagonists 
showing	 the	 sleep-inducing	 effects	 of	 first	 ones	 and	 the	 opposite	 effect	 of	 the	
last ones (Dunwiddie & Worth, 1982; Feldberg & Sherwood, 1954; Fredholm et 
al.,	 1999;	 Ticho	 &	 Radulovacki,	 1991).	 The	 first	 direct	 evidence	 of	 spontaneous	
adenosine	fluctuations	during	sleep-wake	cycle	came	 from	 in vivo microdialysis 
measurements of adenosine in freely behaving animals (Porkka-Heiskanen et al., 
1997). During spontaneous sleep adenosine levels decrease in the cortex, basal 
forebrain, hypothalamus, and brainstem (Porkka-Heiskanen et al., 2000; Porkka-
Heiskanen et al., 1997). However, during prolonged wakefulness (sleep deprivation) 
adenosine levels continue to rise or are stable only in one of these brain regions, the 
basal	forebrain.	Thus,	a	relatively	specific	area,	the	basal	forebrain,	which	appears	
to be central in the regulation of sleep-wake cycle and recovery sleep, has been 
identified.	
One of the best functional theories for adenosine’s role in sleep–wake 
regulation derives from the fact that adenosine, a by-product of energy metabolism, 
may serve as a homeostatic regulator of energy in brain during sleep (Porkka-
Heiskanen & Kalinchuk, 2011). Adenosine is an end product of ATP (adenosine 
triphosphate) utilization (Chikahisa & Sei, 2011). Intracellularly, ATP is metabolized 
to ADP (adenosine diphosphate) and then subsequently metabolized to AMP 
(adenosine monophosphate), which in turns is further metabolized to adenosine 
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by cytosolic 5′-nucleotidase enzyme. Extracellularly, ATP, ADP, and AMP are 
converted to adenosine by ecto-5′-nucleotidases. When ATP is utilized in the cell, 
excess adenosine is transported to the extracellular space. Extracellular adenosine 
concentrations have been shown to increase with increased metabolism and 
increased neural activity (Minor et al., 2001; Pull & Mcilwain, 1972). Under increased 
energy	demand	during	wake	periods,	when	metabolic	rate	is	approximately	30%	
higher than during NREM sleep, adenosine levels increase and promote delta 
activity in NREM sleep (Kalinchuk et al., 2008).
Currently,	 there	are	 known	 four	different	adenosine	 receptors,	A1, A2a, A2b 
and A3 (Fredholm, 2010). For sleep-wake homeostasis the A1 and A2a receptors have 
received the most attention and have been shown to mediate adenosine’s sleep 
inducing	effects	(Satoh	et	al.,	1998;	Strecker	et	al.,	2000).	The	effects	of	adenosine	
in the basal forebrain on recovery sleep are mostly mediated by A1 receptors. 
Perfusion of an A1 receptor antagonist into the basal forebrain reduced recovery 
sleep	after	sleep	deprivation,	and	no	effect	was	observed	by	perfusion	of	an	A2a 
receptor antagonist (Gass et al., 2009).
Regarding the role of adenosine in mood regulation, there are some indirect 
evidences pointing at the association between adenosine and depression. From 
epidemiological	studies,	 it	 is	known	that	consumption	of	caffeine,	non-selective	
A1/A2a	adenosine	receptor	antagonist,	modifies	 the	mood	of	healthy	people	and	
psychiatric	patients	(Greden	et	al.,	1978;	Smith,	2009).	Consumption	of	caffeine	by	
healthy subjects was associated with a reduced risk of depression compared to the 
incidence	of	depression	in	those	with	no	caffeine	intake	(Smith,	2009).	In	animal	
studies, the nonselective activation of adenosine receptors in the brain induced 
depressive-like	symptoms,	whereas	administration	of	caffeine	effectively	reduced	
depressive-like behaviour in mice (El Yacoubi et al., 2003; Kulkarni & Mehta, 1985). 
Selective A2a receptor antagonists also produced antidepressant activity (Yamada 
et	al.,	2014).	One	of	the	possible	mechanism	which	could	explain	these	effects	of	
adenosine can be the ability of adenosine to modulate the release of neuromediators 
directly involved in mood regulation, such as acetylcholine, glutamate, dopamine, 
GABA and serotonin (Dunwiddie & Masino, 2001). Moreover, adenosine has also 
neuroprotective properties mediated through A1 and A2a receptors, which may be 
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involved	during	inflammatory	process	in	depression	and	can	normalize	glutamate	
release (Cunha, 2005)
Apart	from	the	neurochemical	mechanisms,	adenosine	may	affect	depression	
through	 affecting	 sleep.	 Depression	 is	 characterized	 by	 decreased	 SWA	during	
NREM	sleep,	which	reflects	decreased	sleep	intensity	(Borbely,	1987).	This	may	occur	
due	to	insufficiency	of	homeostatic	regulation	of	sleep.	Adenosine	being	one	of	the	
most important homeostatic sleep molecule in the brain (Porkka-Heiskanen et al., 
1997), is known to be decreased in pharmacological animal model of depression 
(Savelyev	et	al.,	2012).	Thus,	 it	might	be	concluded	that	adenosine	deficiency	 in	
depression can contribute to sleep problems found often in depression, and on the 
other side it can aggravate the depressive state by itself. 
2.5. Early life stress as a predisposing factor for depression 
development 
2.5.1 Early life stress as a risk factor for depression
Early childhood and adolescence are extremely sensitive periods in human 
development, during which the brain, especially the systems controlling emotions, 
attention, self-control and stress, are shaped by the interaction with environment. 
Multiple epidemiological studies have indicated a tight association between 
adverse childhood experience and an increased risk to develop depression later 
in life (Edwards et al., 2003; Heim et al., 2008; Kessler, 1997; Kessler et al., 2010). 
The	strong	dose–response	relationship	has	been	found	between	different	types	of	
early life stressors, such as physical or sexual abuse, neglect or loss of the parent, 
and general mental health problems in adulthood. The global prevalence of 
child	sexual	abuse	is	quite	high,	and	is	estimated	to	be	11.8%	overall,	with	higher	
prevalence	 for	girls	 (18.0%)	compared	to	boys	 (7.6%)	 (Stoltenborgh	et	al.,	 2011).	
Recent meta-analysis studies also provided statistics on the global prevalence of 
child	physical	abuse,	physical	neglect	and	emotional	neglect	being	22.6%,	16.3%,	
and	18.4%,	respectively,	with	no	apparent	gender	differences	(Stoltenborgh	et	al.,	
2013a; Stoltenborgh et al., 2013b). An important role of childhood traumatic events 
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in the development of MDD has been also demonstrated in twin studies (Kendler 
et al., 2000; Nelson et al., 2002).
The	most	severe	childhood	adversities	have	significant	effects	on	early-onset	
depression	(defined	as	an	onset	before	age	20)	but	not	on	later-onset	depression	
(Kessler, 1997). This indicates that there is a developmental window, where 
childhood adverse events have the strongest impact on depression vulnerability. 
Furthermore, individuals with early life adverse experience are more vulnerable 
to stress and have lower threshold for developing a depressive disorder in 
response to stressors (Dougherty et al., 2004; Hammen et al., 2000; Kendler et al., 
2004). Interaction between environment and genes contributes to likelihood of 
depression development in response to stressful events in people who experienced 
maltreatment during their childhood (Bradley et al., 2008; Caspi et al., 2003; 
Kaufman et al., 2004). There are a few genes highlighted in these studies, including 
the BDNF (Buchmann et al., 2013; Liu, 2010).
The underlying mechanism through which early life stress increase 
depression vulnerability has been a subject for many studies. There are alterations 
in brain development in children who experienced early life adversities, including 
reduced volume of limbic, cortical brain areas, and interhemispheric connections 
(Pechtel & Pizzagalli, 2011; Teicher et al., 2003; Teicher et al., 2004). It was suggested 
that early life stress interferes with the critical waves of neurogenesis, synaptic 
overproduction,	 and	pruning	of	 synapses	 and	 receptors,	 resulting	 in	deficits	of	
cognitive functions (Teicher et al., 2006).
Studies in rodents and non-human primates have focused on epigenetic 
modifications	of	stress	 reactivity	as	a	 result	of	early	 life	adverse	experience.	These	
studies suggest that early maltreatment (e.g. maternal separation or low maternal 
care)	induces	epigenetic,	structural,	and	functional	changes	in	neural	system	affecting	
cognitive and emotional development (Meaney & Szyf, 2005; Sanchez et al., 2001).
Early	 life	 environment	 can	 shape	 offspring	 epigenome	 and	 affect	 stress	
reactivity in future life. In rodent studies, early life stress has been shown 
to	 cause	 adverse	 alterations	 of	 different	 genes	 expression	 profiles,	 including	
arginine vasopressin, glucocorticoid receptor, and BDNF gene (Schroeder et al., 
2010).		In	rats,	difference	in	maternal	nursing	led	to	different	methylation	level	of	
hippocampal glucocorticoid receptor gene promoter (Weaver et al., 2004), which 
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in	turn	affected	their	stress	responsiveness	in	adulthood.	Early	life	separation	of	
new-born mice from their mothers resulted in a persistent upregulation of arginine 
vasopressin due to hypomethylation of the arginine vasopressin gene enhancer 
region and led to constant release of corticotrophin-releasing hormone (CRH), 
inducing a sustained hyperactivity of the HPA axis (Murgatroyd et al., 2009). Early 
maltreatment	has	been	also	shown	to	affect	BDNF gene silencing in the prefrontal 
cortex due to DNA methylation mechanism that lasted into adulthood and was 
accompanied by abusive behaviour (Roth et al., 2009).
All these changes converge in increased endocrine and autonomic reactivity to 
stress, anxiety-like behaviour, anhedonia, and impairment of cognitive functions. In 
fact,	many	of	the	neurobiological	and	behavioural	effects	of	early	life	stress	in	animal	
models are related to similar signs and symptoms of depressive disorder in humans, 
including sensitization of central stress response systems and changes in epigenome 
(Heim	&	Nemeroff,	2001,	2002;	Heim	et	al.,	2008;	McGowan	et	al.,	2009).	
2.5.2 Animal models of early life stress
Animal models are invaluable tools in studies on mechanisms and 
pathophysiology	 of	 different	 mental	 disorders,	 including	 depression	 (Frazer	 &	
Morilak,	2005;	Fuchs	&	Fliugge,	2006;	Kalueff	et	al.,	2007).	However,	it	should	be	
noted that complex human psychiatric diseases, as depression, are impossible to 
model fully in rodents, especially such symptoms as e.g. low self-esteem, feelings 
of guilt, or suicidality. But a number of core symptoms of human depression do 
have an equivalent in animals (Table 1), and one of them is altered sleep structure.
Table 1. Correlates of core depression symptoms in humans with the possible 
analogous parameters in rodents.
Core symptoms in humans Analogous parameter in rodentsAnhedonia Reduced preference for sweetened solutions Loss of motivation Passive behaviour, low locomotor activitySleep disturbances, altered sleep structure Altered sleep structureAnxiety Anxiety-like behaviour
Cognitive deficits Cognitive deficitsHypercortisolism, hyperactivity of the HPA axis Hyperactivity of the HPA axis
Modified	from	(Schmidt	et	al.,	2011).
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Currently, there is no established adolescent animal model of clinical 
depression. It is important to understand that the developmental progression 
of	 puberty	 and	 adolescence	differs	 between	 humans	 and	 traditional	 laboratory	
animals. In humans, puberty is initiated by an increased secretion of hormones 
from the gonads, such as oestrogens and androgens, and androgens from the 
adrenals	 (Hagenauer	 &	 Lee,	 2013).	 Whereas	 puberty	 in	 humans	 is	 defined	 by	
reproductive	development,	adolescence	is	defined	as	the	period	of	social,	emotional	
and cognitive transition between childhood and adulthood. In animal studies, the 
term	“adolescence”	 is	traditionally	used	specifically	to	refer	to	research	focusing	
on the neural and behavioural changes accompanying the transition from juvenile 
dependence	into	the	relative	independence	of	adulthood	and	lasting	from	artificial	
weaning until the time of attaining reproductive competence and social interaction 
skills.
Of the many animal models of depression in adults, the models based on 
early life stress are probably the most relevant to model early-onset depression 
in humans. Techniques based on manipulation of the mother-infant interaction 
in	rodents	during	the	first	weeks	of	postnatal	life,	which	corresponds	to	the	third	
trimester of fetal development and early postnatal development in humans, are 
widely used for this purpose (Roque et al., 2014; Vetulani, 2013; Wilber & Wellman, 
2009). Maternal separation represents the model of serious childhood incidences 
in humans. It reduces the amount of maternal care for the pups, thereby modelling 
emotional as well as physical child neglect. In this model, newborn pups are 
separated from their mothers during the so-called stress hyporesponsive period in 
rodents, which lasts during postnatal days (PNDs) 2–14 in the rat and PNDs 1–12 
in the mouse and is characterized by low basal ACTH and corticosterone secretion 
and low corticosterone response to stressors (Levine, 1970; Pryce et al., 2005; 
Schmidt et al., 2003). Maintenance of this critical stress hyporesponsive period is 
dependent on maternal care: isolation of the pups from the dam for a single period 
of at least 8 h leads to an increase in ACTH and corticosterone secretion and also 
leads to increased HPA responsiveness to discrete stressors (Pryce et al., 2005). 
Maternal separation in the models of early life stress can be carried out 
for	 different	 intervals	 of	 time,	 ranging	 from	 single	 episode	of	 24	 h	deprivation	
to repeated shorter periods of maternal deprivation of 3, 6, 8, or 12 h. The 
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behavioural and biological consequences of early life maternal separation in adult 
animals resemble those of human depression (Roque et al., 2014). This model 
inflicts	considerable	stress	 for	both	 the	pups	and	 their	mothers	associated	with	
alterations in behavioural, immunological, and endocrine parameters, including 
hyperactivation of HPA axis and increased corticosterone levels (Liu et al., 1997; 
Plotsky & Meaney, 1993; Roque et al., 2014).
Regarding	 the	effect	of	maternal	separation	on	sleep,	several	studies	have	
studied spontaneous and stress-induced sleep in adulthood (Mrdalj et al., 2013; 
Reyes Prieto et al., 2012; Sampath et al., 2014; Tiba et al., 2003; Tiba et al., 2004, 
2008). The core of the reported is following: the majority of the changes manifest 
as	increases	in	different	parameters	of	REM	sleep;	one	study	reported	decrease	of	
REM sleep (Reyes Prieto et al., 2012). Some studies also reported changes in NREM 
sleep (Mrdalj et al., 2013; Reyes Prieto et al., 2012; Sampath et al., 2014).
Taking into account that maternal separation is associated with a profound 
stress for both infants and mothers, it may not be an ideal representation of events in 
human	real	life.	In	this	regard	other	modifications	of	the	mother-infant	interaction,	
which may better simulate the early life stress in childhood, can be of interest. One 
such approach is the model based on changing pups between mothers, namely 
cross-fostering (CF) (Barbazanges et al., 1996; Meaney & Szyf, 2005). The pup 
litters are changed between mothers during the critical postnatal period, which 
is known to be sensitive for environmental stimulation (at the age of PND 2-12) 
(Barbazanges et al., 1996). The age at which the CF procedure is performed has 
a	great	effect	on	the	outcome	(Barbazanges	et	al.,	1996;	Darnaudery	et	al.,	2004).	
Thus, an early adoption, when pups are changed at PND 1 increases maternal 
behaviour and as a result improves cognitive performance and prevents prenatal 
stress-induced	impairments	in	glucocorticoid	feedback	in	offspring	(Barros	et	al.,	
2004; Maccari et al., 1995). Pups that are raised by foster mothers, which adopted 
them later (from PND 5 on), have higher stress reactivity and impaired cognitive 
functioning (Barbazanges et al., 1996). Therefore, the latter procedure can be used 
as an alternative to maternal separation, but there is little or no data regarding its 
link to depression-like phenotype.
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3. Aims and hypotheses of the study
3.1. General aim and hypothesis
Our main hypothesis was that early life stress leaves persistent molecular 
changes in the brain, predisposing to depression and sleep problems development 
in future.
The aim of this thesis was to follow the development of depression and 
concomitant sleep disturbances starting from early life, and study their molecular 
mechanisms.
3.2. Specific aims and hypotheses
The	specific	hypotheses	of	the	study	were:
1) BDNF	 gene	 expression	 has	 an	 exon-specific	 transcription	 pattern	 during	
spontaneous	 sleep	 and	 is	 affected	 by	 sleep	 deprivation	 through	 the	
transcription-silencing	5-methylcytosine	DNA	modification.
2) Cross-fostering induces depressive-like behaviour accompanied by sleep 
changes and decreased BDNF gene expression in involved brain regions.
3) Adolescent depression is characterized by sleep disturbances and slow-wave 
activity abnormalities.
4) Genetically determined variation in BDNF gene (Val66Met) modulates sleep, 
psychomotor development and temperament that can be assessed already at 
early stages of infancy.
The	specific	aims	of	the	study	were:
1) To study the expression dynamics of three activity-dependent BDNF 
transcripts (BDNF1, BDNF 4 and BDNF 9a) and methylation levels of their 
promoters (p1, p4 and p9) in spontaneous sleep and after sleep deprivation.
2) To validate cross-fostering animal model as a model of early life stress 
reflecting	traumatic	early	life	events	happening	in	real	human	life.
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3) To explore sleep structure and slow-wave activity of early-onset depression in 
adolescents.
4) To	find	out	whether	functional	BDNF gene polymorphism (Val66Met), which 
leads to reduced BDNF secretion, is associated with sleep consolidation, 
psychomotor development and temperament at early stages of human 
infancy.
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4. Materials and methods
The study outline is presented in the table 2. Animal models were used to 
study the propagation of depression from early life period to adulthood together 
with concomitant sleep problems and possible underlying molecular mechanisms 
(I, II). Sleep disturbances in early-onset depression were studied in the clinical 
sample of depressed adolescent boys (III). The association between BDNF gene 
polymorphism (Val66Met) and early life development, including sleep was studied 
in the birth cohort (IV). 
Table 2. The study outline showing the original studies by Roman numerals.
Period Early life Adolescence Adulthood
Studied 
parameters
Animal Human (IV) Animal (II) Human (III) Animal (I,II) Human
Sleep x x x
BDNF x x x
Adenosine x
Behaviour x x x x
The topics addressed in the original studies (indicated by the roman 
numerals) are marked with the crosses. Animal studies I and II are focused on 
possible molecular mechanisms of interaction between depression and sleep 
disorders. The focus of clinical study III is sleep abnormalities in adolescent 
depression. Study IV is aimed at the investigation of association between BDNF 
Val66Met polymorphism and early life development.
4.1. Animal studies
4.1.1 Role of exon-specific BDNF expression and methylation at 
different promoters in sleep regulation
4.1.1.1. Rats and housing procedures
Young male Wistar rats (12 weeks old, 300-400g, received from formerly 
Harlan Laboratories B.V., now Envigo, Venray, Netherlands) were housed at 
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constant	 temperature	 (23±1°C)	 and	 humidity	 (50%	 -	 60%)	 under	 12h	 light/12h	
dark cycle (light on at 08:00 h) with ad libitum access to food and water. Animals 
were handled starting at least 5 days before the experiment. All animal procedures 
were performed according to the guidelines of the National Institute of Health 
Guide for the Care and Use of Laboratory Animals, and were approved by the 
experimental Animal Ethics Committee of Southern Finland (animal license 
ESAVI/5028/04.10.07/2014).
4.1.1.2. Sleep deprivation protocol
Thirty six rats were divided into 6 groups: three controls and three SD (Figure 
4). SD was performed from the beginning of the light period (starting at 8 am, or 
zeitgeber	 time	 [ZT0])	 for	 3	 h	 (finished	at	 11	am,	or	ZT3),	 6	h	 (finished	at	 1	pm,	
or	ZT6)	or	 12	h	 (finished	at	 8	pm,	or	ZT12).	Animals	were	sleep	deprived	using	
the	gentle	handling	method	 (Franken	et	al.,	 1991a).	Briefly,	 SD	was	enforced	by	
exposing the rats to novel objects to engage them in exploratory activity. In case 
of 12 h SD, closer to the end of sleep deprivation period animals were subjected 
to external stimulation, such as mild noises, tapping the cage, or direct contact 
with the animal through a soft brush. Control animals were left undisturbed in a 
separate room.
Figure 4. Experimental protocol: non-deprived groups (CTRL) 3, 6 or 12 h and sleep-
deprived	(SD)	groups	3,	6	or	12	h	(N=6	animals	per	each	group).	Modified	from	Study	I.
4.1.1.3. Brain tissue collection
Immediately after SD, rats from both groups, SD and CTRL, were killed by 
carbon dioxide followed by decapitation and the brains were quickly removed. Two 
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mm coronal slices of the target areas were prepared. The basal forebrain and frontal 
cortex were dissected from the slices with a scalpel. The tissues were immediately 
placed into RNA-stabilizing reagent RNAlater (Sigma-Aldrich, Helsinki, Finland), 
frozen on dry ice and stored at -80 °C.
4.1.1.4. BDNF messenger RNA analysis
After brains homogenization total RNA was immediately extracted using the 
RNeasy Plus Mini Kit (Qiagen, Helsinki, Finland), according to the manufacturer’s 
instructions.	One	μg	of	 total	RNA	was	reverse-transcribed	using	a	Maxima	first	
standard	cDNA	synthesis	 kit	 (Thermo	Scientific,	Helsinki,	 Finland).	The	cDNA	
regions	 marked	 on	 figure	 5	 were	 amplified	 with	 a	 Maxima	 SYBR	 Green	 qPCR	
Master	Mix	(Thermo	Scientific)	and	selected	primers	(details	in	the	Study	I).	The	
amplification	was	done	using	a	LightCycler	480	real-time	polymerase	chain	reaction	
(PCR)	 system	 (Roche,	 Espoo,	 Finland).	 Relative	 quantification	 of	 template	was	
performed	using	the	ΔΔCt	method	(Livak	&	Schmittgen,	2001),	with	experimental	
cDNA data normalized to a housekeeping gene level (glyceraldehyde-3-phosphate 
dehydrogenase, GAPDH).
Figure 5. Each 5’ exon is controlled by its own promoter and alternatively spliced to the protein 
coding	exon	9	(marked	with	grey	box),	resulting	in	different	BDNF transcripts (here shown 
BDNF1, BDNF4 and BDNF9a) coding for the same protein. Genomic regions p1, p2, p4, p9 
(marked	with	black	rectangles)	were	amplified	in	the	methylated	DNA	immunoprecipitation	
(MeDIP) experiment; 1–9, 4–9 and 9a–9 exon junction regions of BDNF transcripts were 
amplified	in	the	mRNA	expression	experiment.	Modified	from	Study	I.
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4.1.1.5. Methylated DNA immunoprecipitation
Methylated	DNA	immunoprecipitation	(MeDIP)	is	an	efficient	technique	of	
detection of methylated DNA using the anti-5-methylcytosine (5mC) antibodies 
(Thu et al., 2009). In brief, genomic DNA is randomly sheared by sonication and 
immunoprecipiteted	(IP)	with	a	monoclonal	antibody	that	specifically	recognizes	
5-mC.	The	DNA	amount	in	the	5mC	IP	fraction	reflects	the	amount	of	methylated	
CpG dinucleotides on genomic DNA. The resulting enrichment of methylated 
DNA in the IP fraction can be determined by PCR to assess the methylation state 
of individual regions.
GeneJET	Genomic	DNA	Purification	Kit	 (Thermo	Scientific)	was	used	 for	
purification	 of	 genomic	 DNA	 from	 the	 same	 rat’s	 brain	 tissues	 that	were	 used	
for	 RNA	 purification.	 Genomic	 DNA	 (1.2	 μg)	 in	 100	 uL	 Tris/ethylenediamine	
tetraacetic acid (EDTA; TE; 10 mM Tris pH 8.0, 1 mM EDTA) was sheared randomly 
by sonication to the 200–500 base pairs size using a Vibra-Cell Ultrasonic Liquid 
Processor (Sonics & Materials Inc., Newtown, CT, USA), and then heat-denatured. 
One	part	(0.2	μg)	of	sheared	DNA	(input)	was	stored	at	+4	°C	during	the	IP	reaction,	
while	the	remaining	five	parts	(1	μg,	IP	sample)	was	used	for	the	IP	reaction.	The	IP	
sample	was	incubated	with	1	μg	of	the	anti-5mC	monoclonal	antibody	(clone	33D3;	
Diagenode,	Liege,	Belgium)	overnight	at	+4	°C	and	precipitated	with	the	protein	G	
Dynabeads	(Invitrogen,	Helsinki,	Finland)	for	2	h	at	+4°C.	Proteinase	K	was	used	
for	digestion	of	 immunoprecipitated	DNA–antibody	complex	 for	 3	 h	at	 +56	 °C.	
After	this	the	released	DNA	was	column-purified	using	the	GeneJET	DNA	Cleanup	
Micro	Kit	(Thermo	Scientific).	
Final input and IP DNA samples were diluted in 100 uL TE and kept at -20 °C. 
The resulting enrichment of methylated DNA in the IP versus the input fraction 
was	quantified	by	PCR	using	a	LightCycler	480	real-time	PCR	system	(Roche)	with	
a	Maxima	SYBR	Green	qPCR	Master	Mix	(Thermo	Scientific)	and	the	primers	for	
BDNF promoters p1, p4 and p9, and the promoter p2, less regulated by neuronal 
activity	or	SD	(Figure	5).	Relative	quantification	of	each	IP	template	was	normalized	
to its corresponding input level and multiplied by 5 to equalize the original amount 
of the IP and input genomic DNA samples.
Data	followed	a	normal	distribution	and	the	main	effects	of	sleep	deprivation	
or circadian time (SD or ZT) factors were analysed by using two-way analysis of 
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variance	(ANOVA).	Effect	of	ZT	within	the	same	treatment	group	(CTRL	or	SD)	
was analysed by one-way ANOVA followed by Fisher’s post-hoc test (protected least 
significant	difference,	PLSD).	The	CTRL	and	respective	SD	groups	on	the	same	ZT-
point (3, 6 or 12 h) were compared using a Student’s unpaired two-tailed t-test. 
Cohen’s	d	was	used	 to	estimate	 the	effect	sizes	as	 follows:	small	≥	0.2,	medium	
≥	0.5,	 large	≥	0.8.	The	group	differences	showed	medium	effect	sizes.	The	linear	
regression ANOVA analyses were performed using a StatView statistical package 
(Study I). 
4.1.2 Role of early life stress in depression development and sleep 
disturbances
4.1.2.1. Rats, cross fostering model and housing procedures
Modification	of	the	mother–infant	interaction	during	early	postnatal	period,	
namely	CF,	has	specific	effects	on	the	development	of	offspring	characterized	by	
higher stress reactivity and impaired cognitive functioning (Barbazanges et al., 
1996).	Different	approaches	have	been	used	to	model	CF	but	they	all	based	on	the	
assumption	that	the	offspring	development	is	programmed	by	the	prenatal	and/or	
postnatal maternal environment (McCarty, 2017). 
In our study, pup litters of Hannover Wistar rats (average size 10 pups) were 
changed between mothers at the end of stress hyporesponsive period, on PND12 
(Barbazanges et al., 1996). The mothers were carefully removed from their home 
cage and temporarily placed in empty cages containing some nesting material and 
food	pellets.	Meanwhile,	the	litters	were	placed	in	artificial	nests	made	from	soft	
nesting	material	placed	on	top	of	two	rubber	gloves	filled	with	warm	water.	The	
bedding in home cages was quickly changed. The whole procedure took no longer 
than 5 min. The litters were placed in the cage of their foster mothers, and the 
mothers were returned to their home cages. After some reorganization of the pups 
and the nest, the dams calmed down and began to lactate. The group of mothers 
with litters, which served as a control (CTRL) group was left undisturbed. Since it 
has been previously shown (Barbazanges et al., 1996) that the short separation by 
itself does not lead to behavioural or hormonal changes, we did not have additional 
control	group	for	checking	any	possible	effects	of	a	single	brief	separation.
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Eight CTRL and 9 CF nests were included in this study. In total, 43 male and 
41 female rats were used for this study, which were kept at the same conditions as 
were described above in the section 3.1.1.1. In adulthood, one male and one female 
sibling per litter was used for each measurement. The timeline of the experimental 
procedures	is	represented	in	figure	6.	
Figure 6. The	timeline	of	the	experimental	procedures.	PND:	postnatal	day,	OF:	open	field	
test,	 SPT:	sucrose	preference	 test,	CTRL:	control	 rats,	CF:	cross-fostering	rats.	Modified	
from Study II.
4.1.2.2. Behavioural tests
Sucrose preference test. Sucrose preference test (SPT), is widely used for 
assessing the anhedonia-like phenotype (lack of interest in rewarding stimuli) 
in laboratory rodents. It has been shown, that the chronic mild stress procedures 
induce a substantial reduction in consumption of sucrose solutions, which can be 
interpreted as a decreased sensitivity to reward in stressed animals (Katz, 1982). 
Preference is measured by volume and/or weight of sweet liquid consumed during 
testing period, which is then converted to a percent preference compared to a water 
only.
SPT was performed in individually housed rats once during their adulthood 
(PND 105). The test was performed in two consecutive sessions. During the training 
session, which lasted for 48 h, animals were provided simultaneously with 2 bottles 
in	 the	 home	 cage,	 one	 containing	 a	 1%	 sucrose	 solution,	 the	 other	 containing	
tap water. The position of the bottles was switched twice a day to avoid place 
preference. The volume of tap and sucrose water intake was measured every 24 h. 
After the training session, animals were deprived of food and water for 18 h with 
following test session, which lasted for 2 h. The amount of water remaining in each 
bottle was measured at the end of the testing period. Food and water deprivation 
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before test session was performed based on previous research showing that it is 
a necessary component of successful SPT in chronically stressed animals (Katz, 
1982; Remus et al., 2015). Overnight food and water deprivation motivates rodents 
to consume liquid during a limited amount of time during the light cycle where 
their liquid intake is typically low. On the other hand, food and water deprivation 
prior to SPT may by itself act as a stressor. This facilitates the anhedonic response 
in chronically stressed rats, which is associated with such physiological changes 
as	 general	 hypoglycaemia,	 increase	 in	 hippocampal	 pro-inflammatory	 cytokine	
level, and elevated release of cortical dopamine and norepinephrine compared to 
control rats (Remus et al., 2015). Thus, rodents with depressive-like behaviour may 
have	differential	responses	to	food	and	water	deprivation	that	results	in	changes	in	
sucrose intake compared to control animals.
The	sucrose	preference	score	was	expressed	as	percent	of	total	fluid	intake	
(sucrose	 preference	 =	 sucrose	 water	 consumed/total	 liquid	 consumed	 ×	 100%)	
(Bhagya et al., 2008). Factorial ANOVA (factors: sex, treatment) was used to 
evaluate	the	effect	of	these	factors	on	sucrose	preference	(Study	II).
Open field test. The symptoms of anxiety are highly prevalent in depression 
disorder.	In	animal	models	anxiety-like	behaviour	can	be	assessed	by	the	open	field	
(OF) test. This test provides an opportunity to assess novel environment exploration, 
general locomotor activity, and initial screen for anxiety-related behaviour (Prut & 
Belzung, 2003). Although OF test is commonly used for the assessment of anxiety-
like	behaviour,	it	is	known	that	the	activity	in	OF	is	also	affected	by	depression	and	
chronic	stress	(Kalueff	&	Tuohimaa,	2004).	Animals	with	depressive-like	behaviour	
demonstrate reduced basal activity in OF and avoidance of open area, representing 
a "refractory loss of interest" (Katz et al., 1981).
The OF test apparatus consisted of a white circular arena (diameter 80 cm), 
enclosed by white walls. The arena was divided into 19 equal sectors by lines drawn 
on	the	bottom.	The	apparatus	was	placed	in	a	quiet	room.	Rats	were	first	weighed	
and then placed in the center of the OF arena. The activity of each rat during the 
test session (5 min) was video recorded. Between tests the apparatus was cleaned 
with tap water followed by ethanol and then wiped until dry.
The videos were analyzed as follows. Horizontal (number of squares crossed in 
the inner and outer areas, latency to leave centre) and vertical (rearings [standing on 
41
hind legs]) activity, grooming (latency to start self-grooming, duration and number 
of self-grooming episodes), and excretory activity (defecations and urinations 
number) were scored. Factorial ANOVA (factors: sex, age, and treatment) was used 
to	analyze	the	effect	of	these	factors	and	their	interaction	on	weight	of	the	animals	
and their activity in OF test (Study II). 
Rats from CF and CTRL groups were subjected to OF test during 2 time 
points: adolescence (PND 45) and adulthood (PND 100). Half of the adolescent 
animals	were	sacrificed	a	few	days	after	the	test	for	brain	tissue	collection	(for	BDNF 
expression measurements) and another half were kept alive until they reached 
adulthood. 
4.1.2.3. Brain tissue collection
Rats	were	sacrificed	by	decapitation	using	a	guillotine,	and	the	brains	were	
quickly removed. Two mm coronal slices of the target areas were prepared. The 
basal forebrain, frontal cortex, and hypothalamus were dissected from the slices 
with a scalpel. The tissues were placed into RNA-stabilizing reagent RNA later 
(Sigma-Aldrich,	Helsinki,	Finland),	frozen	on	dry	ice,	and	stored	at	−80°C.
4.1.2.4. BDNF messenger RNA analysis
The brain tissues were homogenized and RNA was immediately extracted 
using RNA Later Lipid Mini Tissue Kit according to the manufacturer’s protocol 
(Qiagen, Helsinki, Finland). DNase treatment of the RNA fraction was carried 
out using the RNAse-Free DNase Set (Qiagen, Helsinki, Finland) as a precaution 
against genomic DNA contamination. The measurement of RNA fraction for purity 
and concentration was carried out with Nanodrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Rockland, DE, USA).
TaqMan RT-qPCR was performed using LightCycler 480 Real-Time PCR 
System (Roche, Espoo, Finland) and TaqMan gene expression assays (Applied 
Biosystems,	Foster	City,	CA,	USA).	One	μg	of	total	RNA	was	reverse	transcribed	
using	a	Maxima	first	standard	cDNA	synthesis	kit	 (Thermo	Scientific,	Helsinki,	
Finland).	cDNA	samples	were	amplified	using	a	TaqMan	Universal	PCR	MasterMix	
and the commercial gene expression assays with probes for BDNF (Rn02531967_s1) 
and ACTB (Rn00667869_m1) from Applied Biosystems. 
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The PCR program used for the experiment was as follows: 50°C 2 min - 95°C 
1 min and 50 cycles of repeating 95°C for 15 seconds and 60°C for 1 min. All samples 
were	run	 in	triplicates.	Relative	quantification	of	template	was	performed	using	
the	ΔΔCt	method.	Experimental	cDNA	data	was	normalized	 to	a	housekeeping	
gene (actin beta, ACTB) level. Factorial ANOVA (factors: sex, age, and treatment) 
was	used	to	analyze	the	effect	of	these	factors	and	their	interaction	on	BDNF gene 
expression in studied brain regions (Study II). 
4.1.2.5. Surgery, in vivo microdialysis and polysomnographic 
recordings and analysis
Under general anesthesia, 14 male and 14 female adult rats from CTRL and 
CF groups, were implanted with electrodes for the recording of the EEG/EMG and 
with a unilateral guide cannula for the microdialysis probe. 
The	 rats	 were	 anesthetized	 with	 isoflurane	 (IsoFlo	 Vet	 100%,	 Abbott	
Laboratories	 Ltd,	 England)	 (5%	 induction;	 2%	 maintenance)	 and	 placed	 in	 a	
stereotaxic device. Fifteen minutes before starting the surgery, rats were injected 
with buprenorphine (Temgesic, Indivior UK Limited, Slough, UK, 0.05 mg/kg, s.c.). 
After exposing, cleaning and disinfecting the skull bone, two bipolar screw EEG 
electrodes were placed fronto-parietally into the skull: 2 mm rostral, 2 mm lateral 
from bregma, and 4 mm rostral, 1 mm lateral from lambda. While two silver wire 
electrodes were inserted into the neck muscles for EMG recording. A unilateral 
guide cannula (CMA 11 Guide, CMA/ Microdialysis, Stockholm, Sweden) was 
implanted aiming at the basal forebrain (BF) cholinergic area (horizontal diagonal 
band of Broca, the substantia innominata and the magnocellular preoptic area; the 
coordinates respective to bregma: anterior = –0.3 mm; lateral = 2.0 mm; vertical 
= –5.5 mm). The schematic representation of coronal brain section with targeted 
area	is	represented	in	figure	7.	Electrodes	and	guide	cannula	were	fixed	to	the	skull	
with acrylic dental cement.
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Figure 7. The schematic representation of coronal brain section with targeted BF area 
marked	with	grey	circle.	Modified	from	(Paxinos	&	Watson,	1998).
After surgery, rats were single-housed in Plexiglas boxes; the day after the 
surgery they were injected with antibiotic/analgesic (1.6 g/kg A-Pen, Orion Pharma 
Oy,	Espoo,	Finland	+	6	mg/kg	lidocaine,	Orion	Pharma	Oy,	Espoo,	Finland,	i.p.).	
Then they were connected to recording cables through swivels, and allowed to 
recover up to 1 week; a 2 days recording was taken from each rat to estimate their 
sleep-wake cycle. The experiments were not started until their behaviour and 
sleep–wake cycle had normalized. 
A microdialysis probe (CMA11 Microdialysis probe; 14 mm shaft length, 2 mm 
dialyzing membrane length, 0.24 mm diameter; CMA/Microdialysis) was inserted 
through the guide cannula into the basal forebrain and inlet and outlet tubing (1.5 
m	pieces	of	fluorinated	ethylene	propylene	tubing;	CMA/Microdialysis)	connected	
to the probe the day before the beginning of the experiment. 
Half an hour prior to the onset of sample collection, at 09:30 AM, microdialysis 
tubing	was	connected	to	the	pump	(model	R99-EMZ,	Razel	Scientific	Instruments,	
Vermont, USA) and the fraction collector (Eicom EFC-82 Fraction Collector, San 
Diego, CA, USA). After that continuous perfusion of the microdialysis probe with 
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artificial	cerebrospinal	fluid	(aCSF)	(147	mM	NaCl,	3	mM	KCl,	1.2	mM	CaCl2,	1	mM	
MgCl2)	was	performed	at	a	rate	of	1	μL/min	throughout	the	light	period	of	baseline	
(BL)	day	(9:30	AM-8:30	PM).	The	samples	(30	μL	each)	were	collected	at	30-min	
intervals	and	then	stored	at	−80	°C	until	assayed.	
After	finishing	the	experiments,	the	animals	were	sacrificed	by	administrating	
a lethal dose of pentobarbital (100 mg/kg Mebunat, i.p., Orion Pharma Oy, Espoo, 
Finland).	The	verification	of	the	probe	location	was	done	by	an	ink	injection	through	
a	modified	microdialysis	probe	inserted	into	the	guide	cannula.	After	that	the	brains	
were	removed,	frozen	on	dry	ice,	and	stored	at	−80°C.	Twenty	micrometer	coronal	
sections were cut on a freezing microtome, stained with Toluidine Blue (Sigma-
Aldrich), dehydrated with ethanol, and dried. The probe locations were visually 
inspected under the light microscope. Only animals with probe tips located in the 
BF cholinergic area were included in the analysis (n = 7 CTRL and 6 CF males; n = 
5 CTRL and 5 CF females).
EEG/ EMG recordings were performed during the microdialysis 
experiments.	EEG/	EMG	signals	were	sampled	at	271	Hz,	amplified	(gain	5000)	
and	analogically	filtered	(high	pass:	0.3	Hz;	 low	pass	 100	Hz)	using	the	Spike2	
program (version 5.19; Cambridge Electronic Devices Ltd., Cambridge, UK). The 
recordings	were	semi-automatically	scored	off-line	at	4-s	epochs	for	NREM,	REM	
sleep, and wakefulness using Autoscore-1.7 script and then manually checked 
using Sleepscore v1.01 script (Cambridge Electronic Design) according to the 
common criteria (Zant et al., 2012).
The EEG power spectra (in square microvolts) were calculated with Spike2 
separately for consecutive 4-s NREM epochs (fast Fourier transform (FFT) routine 
512; Hanning window, 0.54 Hz resolution) within a frequency range of 1.08-29.84 
Hz and averaged over the time period that was investigated. The power spectra in 
NREM sleep for delta range (1.08-3.79 Hz) in recovery sleep during one hour of 
post-sleep deprivation period (4:00 PM – 5:00 PM) and respective period of BL 
day were normalized to the total NREM power of SD and BL days, respectively. 
Factorial repeated measures ANOVA (between-subject factors: sex and treatment, 
within-subject	factor:	SD)	was	used	to	analyze	the	effect	of	these	factors	and	their	
interaction on NREM sleep delta power (Study II).
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4.1.2.6. Experimental days
The baseline day, when animals were left undisturbed, served as a reference 
to which subsequent EEG recordings obtained during the SD day were compared 
to. During the BL day rats were connected to microdialysis tubings during 30 min 
after lights-on and perfusion with aCSF was started at 09:30 AM. Perfusion was 
stopped	30	min	before	lights-off	(i.e.,	08:30	PM).
Sleep deprivation day was following the BL day. SD lasting for 3h was 
performed by gentle handling as was described in the section 3.1.1.2. (Franken et 
al.,	1991a).	Briefly,	SD	was	enforced	by	exposing	the	rats	to	novel	objects.	Every	new	
object	was	introduced	into	the	cages	just	following	the	first	signs	of	slow	waves	in	
the EEG recordings. SD was started 4 h after lights-on (at 01:00 PM) and lasted 
until	4:00	PM.	After	finishing	SD	the	animals	were	left	undisturbed.	The	post-SD	
recovery sleep during remaining light period (4:00 PM to 09:00 PM) was compared 
to the corresponding hours of BL day.
Analysis of vigilance state-related parameters (wake, NREM, REM sleep 
duration, and number of REM sleep onsets) was performed by using factorial 
ANOVA (factors: sex, treatment) for spontaneous sleep (separately for the light 
and the dark periods of the day). Recovery sleep was analyzed using factorial 
repeated measures ANOVA (between-subject factors: sex and treatment, within-
subject factor: SD) during the remaining light period after ending of SD (04:00 PM 
to 09:00 PM) separately for NREM and REM sleep.
4.1.2.7. Microdialysis adenosine analysis
All samples collected during the microdialysis experiments were used for 
measuring adenosine using a high-performance liquid chromatography (HPLC) 
assay as described in (Savelyev et al., 2012).
The mobile phase, consisting of ammonium acetate 50 mM, tetrabutyl-
ammonium	hydrogen	sulphate	0.2	mM,	EDTA	1	mM	in	15%	of	MeOH,	pH	5.6,	
was	passed	through	the	column	at	a	flow	rate	of	1	ml/min.	Ten	microliters	of	the	
first	30	min	sample	of	every	hour	from	BL	and	SD	days	were	injected	through	a	
Kinetex ® C18 column (100A, 150 × 4.60 mm, particle size: 5 micron, Phenomenex, 
USA), coupled with a pre-column (KJO-4282, Phenomenex, USA). Adenosine was 
detected at a wavelength of 460 nm and its concentrations were determined by 
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comparing sample peak areas with those of standards (AMP, adenosine, cAMP, 
cdAMP, Sigma-Aldrich) using LabSolutions software (Shimadzu). Detection 
limit:	0.1	nM;	linear	range	of	the	assay:	0.1	nM	-	50	nM;	coefficient	of	variation	 
<	10%.	
The basal adenosine level was determined as the average adenosine 
concentration from the samples collected during the baseline day (09:30 AM–08:30 
PM). Analysis of adenosine level in BF was performed for spontaneous sleep during 
the light period. Factorial ANOVA (factors: sex, treatment) was used to reveal the 
effect	of	sex	and	CF	treatment	on	adenosine	level	in	BF	(Study	II).
4.2. Human studies
4.2.1 Role of BDNF Val66Met polymorphism in early life sleep, 
temperament and psychomotor development
4.2.1.1. Study cohort
The Finnish CHILD-SLEEP birth cohort was used in this study. Data were 
collected at Tampere University Hospital (TAYS) during the period from April 
2011 to January 2013 (for details, see (Juulia Paavonen et al., 2017)). Altogether 1678 
families participated in the study. The umbilical cord blood samples for genetic 
analyses	were	collected	from	1501	newborns	(from	89.5%	of	the	eligible	families),	
with the genotype data available from 1406 individuals. We excluded infants 
with missing phenotype data (232 infants). Since it is known that compromised 
birth weight and low 5-minute Apgar scores are predictors for developmental 
abnormalities throughout childhood and later in life (Gampel & Nomura, 2014) 
the infants with low or high birth weight (2500 g < weight < 4500 g; 51 infants) 
and with low Apgar score at 5 min (<7; 4 infants) were also excluded from the 
analysis. The cohort used for the analysis consisted of 1119 infants at the age of 3 
months	(79.6%	of	the	genotyped	sample)	and	994	infants	at	the	age	of	8	months	
(70.7%).	
The ethics approval for CHILD-SLEEP was obtained from the Ethics 
Committee of Pirkanmaa Hospital District (R11032/9.3.2011).
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4.2.1.2. Sleep assessment
Sleep quality of infants at both ages (3 and 8 months) was assessed by the Brief 
Infant Sleep Questionnaire (BISQ) completed by the parents. The questionnaire 
variables that were chosen for further analysis included: 1) night time sleep duration 
(between 7:00 PM and 7:00 AM); 2) daytime sleep duration (between 7:00 AM 
and 7:00 PM); 3) total sleep time (TST; calculated as sum of night and daytime 
duration); 4) number of night awakenings. To assess the development of sleep 
consolidation, a proportion of night sleep in relation to TST (night sleep/TST) was 
calculated. All parameters were correlated to the BDNF Val66Met polymorphism.
In order to collect additional information about the sleep quality of infants, 
a subsample (N=88) of infants underwent ambulatory home polysomnographies 
at	 the	age	of	 1,	 8	and	 24	months	as	described	 in	 (Satomaa	et	al.,	 2016).	 Briefly,	
the ambulatory polysomnographic recordings were obtained using the Embla 
Titanium system. EEG (6 channels: F4-A1, C4-A1, O2-A1, F3-A2, C3-A2, O1-A2), 
EOG (right and left), and chin EMG were recorded. The polysomnographic 
recordings were scored into the sleep stages in 30-s epochs using Somnologica 
Studio 5.0 software by two independent, experienced clinical neurophysiologists. 
The polysomnographic data for 57 (25 boys and 32 girls) infants was available at the 
age of 8 months and was used in this study. Three polysomnographic parameters 
were taken into analysis for this study: ratio between REM and NREM sleep (REM/
NREM	ratio,	as	a	criteria	of	sleep	pattern	maturation),	sleep	efficiency	index	(SEI;	
calculated as sum of all NREM stages and REM sleep, divided by the total time 
in bed and multiplied by 100) and wakefulness time after sleep onset (WASO; 
reflecting	sleep	fragmentation).
4.2.1.3. Psychomotor development assessment
Vocalization,	 socioemotional,	 fine	 and	 gross	 motor	 development	 were	
assessed	at	the	age	of	3	and	8	month	by	using	the	modified	version	of	the	brief	
parent questionnaire, which was developed for children aged from 1 to 12 months 
(Lyytinen, 2000; Nieminen, 2004). The questionnaire consisted of 4 scales: i) 
vocalization	(10	items);	ii)	socioemotional	development	(13	items);	iii)	fine	motor	
development (15 items); iv) gross motor development (12 items). The scales were 
scored on a three point scale (0 = not observed, 1 = observed once, 2 = observed 
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many times) about the frequency of certain behaviour. The sum of each scale was 
used for the analysis.
4.2.1.4. Temperament measurements
Temperament,	 defined	 as	 the	 constitutional	 traits	 that	 drive	 individual	
differences	in	reactivity	and	self-regulation,	is	an	important	predictor	of	social,	
intellectual, and behavioural development (Gartstein & Rothbart, 2003). The 
temperament was assessed at the age of 8 months by using the short version of 
revised Infant Behaviour Questionnaire (IBQ-R 91 items; 14 scales). The IBQ-R 
measures infant temperament scored on a seven point Likert scale (1 = never, 7 = 
always),	about	the	frequency	of	certain	behaviours	in	specific	situations	(playing,	
bathing, etc.) of the previous week. The means were used for the analysis. The 
IBQ-R consists of 14 scales, which in turn compose three overarching factors: 
positive	 and	 negative	 affectivity,	 and	 orienting/regulatory	 capacity.	 Positive	
affectivity	indicates	an	infant's	tendency	for	energetic	activity,	positive	affect,	and	
high intensity pleasure, and includes the following scales: Smiling and Laughter, 
High Intensity Pleasure, Activity Level, Approach, Perceptual Sensitivity, and 
Vocal	Reactivity.	Negative	affectivity	reflects	an	infant's	constitutional	tendency	
towards negative emotions and distress, and includes such scales as Fear, Distress 
to Limitations, Sadness, and Falling Reactivity (negatively loading).  Orienting/
regulatory	capacity	dimension	 relates	 to	an	 infant	 style	of	affective	 regulation	
including greater impulsivity, fearfulness, and orienting, and it includes 
Duration	of	Orienting,	 Soothability,	Cuddliness/Affiliation,	and	Low	 Intensity	
Pleasure scales (Gartstein & Rothbart, 2003). These three dimensions of IBQ-R 
are known to be analogous to the adults’ personality traits of extraversion, 
neuroticism and conscientiousness, respectively (Putnam et al., 2014).  Adequate 
reliability and validity of this parent-report instrument have been previously 
documented (Gartstein & Rothbart, 2003; Parade & Leerkes, 2008). In our study 
these three main dimensions were investigated in relation to the BDNF Val66Met 
polymorphism.
4.2.1.5. Genotyping
Umbilical cord blood samples for genetic analyses were collected from 
newborns at birth. DNA extraction were done using standard methods at the 
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National Institute for Health and Welfare. Genotyping of informative SNPs 
including functional BDNF SNP (rs6265, or Val66Met) was done with Illumina 
Infinium	PsychArray	BeadChip.
4.2.1.6. Statistical analysis
All statistical analyses were performed with SPSS v.22 (IBM Corp., Armonk, 
NY,	USA).	The	data	came	from	a	normal	distribution.	First,	the	effect	of	gender	on	
studied traits was revealed by one-way ANOVA. Then testing of association between 
BDNF Val66Met	variation	and	different	characteristics	of	infant	development	was	
done	by	one-way	ANOVA	 in	case	when	gender	did	not	have	a	significant	effect,	
or	two-way	ANOVA	in	case	when	the	previous	analyses	had	shown	a	differences	
between boys and girls at P<0.05 (not corrected for multiple testing). Analyses 
were performed with the BDNF SNP allele dosage (under additive model, three 
levels: Val66Val, Val66Met and Met66Met) and gender as the independent factors 
and traits of interest as the dependent variables. The analyses were performed 
separately at the age of 3 and 8 months. 
Both P-values, not corrected for multiple testing (P) as well as corrected 
values (by multiplying observed P- value on number of comparisons (PBonf), 9 
comparisons at the age of 3 months and 16 at the age of 8 months), are shown 
in the results’ tables. A probability level of PBonf<0.05 was considered to indicate 
statistical	significance	for	the	genetic	analyses.	
Power calculations were performed with the Genetic Power Calculator 
(http://pngu.mgh.harvard.edu/~purcell/gpc/) (Purcell et al., 2003) assuming an 
additive	model,	1	%	quantitative	trait	locus	(QTL)	variance,	5%	MAF	and	perfect	
linkage disequilibrium between QTL and the marker.
4.2.2 Sleep disturbances in depressed adolescents
4.2.2.1. Participants
A total of 20 non-medicated adolescent boys (age: 15.9±0.8 y) participated in 
the	study.	Ten	of	them	were	patients	suffering	from	depressive	and/or	sleep	disorder	
symptoms recruited from the Helsinki University Central Hospital Department 
of Adolescent Psychiatry outpatient units, and ten of them were healthy controls 
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recruited	via	advertisements	in	a	newspaper	for	hospital	staff.	Exclusion	criteria	for	
all	participants	consisted	of	mental	retardation,	insufficient	knowledge	of	Finnish	
language, current use of medication, chronic somatic illness, substance abuse/
dependence, principal Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV) diagnosis other than depressive/sleep disorder.
All subjects underwent detailed clinical and psychiatric evaluation. All 
adolescents were medicine-free during the study, and the presence of somatic 
conditions and structural brain pathologies were ruled out based on brain MRI 
and blood samples. One patient was excluded from the analyses because he 
was diagnosed with a circadian rhythm sleep disorder only. Nine patients were 
diagnosed with depressive disorder according to the DSM-IV. 
Diagnostic	 assessment	 was	 performed	 with	 the	 Schedule	 for	 Affective	
Disorders and Schizophrenia for School-Age Children—Present and Lifetime 
version (K-SADS-PL) (Kaufman et al., 1997). Depression symptom severity was 
further	 evaluated	with	 two	different	 scales:	 the	 self-administered,	 21-item	 Beck	
Depression Inventory (BDI-21) (Beck et al., 1961), and the Hamilton Depression 
Rating Scale (HDRS) administered by a clinician (Hamilton, 1960). Insomnia 
symptoms were assessed by Athens Insomnia Scale (AIS) (Soldatos et al., 2000). 
Polysomnographic data were not available for one patient due to drop out, leaving 
8 patients and 10 control subjects in the analyses of the current study.
Written informed consent for study participation was received both from the 
participants and their parents or legal guardians. The study protocol conformed 
to the Declaration of Helsinki and was approved by the ethics committee of the 
Helsinki University Central Hospital. 
4.2.2.2. Blood sampling and testosterone measurement
Serum testosterone levels were measured from peripheral venous blood 
samples taken in the morning according to standard laboratory procedure at the 
Helsinki University Central Hospital Laboratory (HUSLAB). Testosterone was 
measured according to accredited laboratory methods (Liquid chromatography-
tandem mass spectrometry). The blood samples were taken after the clinical 
interview with varying interval (average time between interview and blood 
sampling for patients 11 days, for controls - 39 days). 
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4.2.2.3. Polysomnographic recordings and sleep scoring
Polysomnographic recordings were conducted in subjects’ home environment 
with ambulatory recording devices (Embla, Flaga Hf. Medical devices; EEG 
positions according to the International 10-20 system; derivations F4-M1, C4-M1, 
O2-M1 and backup derivations F3-M2, C3-M2, and O1-M2; sampling rate 200Hz) 
for two consecutive nights. EEG, EMG and EOG were recorded according to the 
standard criteria and the whole recording period was manually scored for sleep 
stages	in	30	s	epochs	by	a	certified	sleep	technician	blinded	to	the	patient/control	
status of the subjects. First recording night served as an adaptation night and 
second night has been used for the sleep and power spectral analyses. 
The following sleep parameters were calculated from the scored data: TST, 
sleep	efficiency	(time	asleep	relative	to	sleep	period,	which	was	calculated	as	time	
from sleep onset through last epoch of sleep), SWS and REM sleep latencies (time 
from	 sleep	 onset	 until	 first	 SWS	 or	 REM	 sleep	 episode,	 correspondingly),	 and	
number	of	awakening	episodes.	Data	were	normally	distributed	and	the	difference	
between depressed and control groups was analysed by one-way ANOVA. Cohen’s 
d	was	used	to	estimate	the	effect	sizes	as	follows:	small	≥	0.2,	medium	≥	0.5,	large	≥	
0.8.	The	group	differences	were	within	the	range	of	medium	effect	size.
NREM periods used for power spectral analysis were determined as 
a succession of sleep stages 1, 2, and 3 with a duration of 15 mins or more and 
terminated by REM sleep or wakefulness of least 5 mins. No minimum REM sleep 
duration	was	required	for	the	first	REM	sleep	episode.	Only	the	first	three	episodes	
of NREM sleep were included in the power spectral analysis, since all the subjects 
had at least three NREM sleep episodes during the night.
4.2.2.4. Power spectrum analysis
The EEG (sampling rate 200 Hz) was subjected to power spectrum analysis 
off-line	with	the	help	of	Spike	2	software	(version	8.07	CED,	Cambridge).	Power	
spectrum (Hanning window) from central C4-M1 and frontal F4-M1 channels were 
computed, using FFT size of 512 Hz giving a resolution of 0.39 Hz. The spectral 
power was averaged in 30 sec epochs to be of identical length with the stage-
score epoch length. Power spectra of SWA range (delta frequencies 0.39–3.91Hz) 
were calculated separately for NREM episodes 1, 2, and 3 from each derivation. 
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Spectral powers were normalized in each recording to the mean SWA power across 
two	derivations	during	the	first	 three	NREM	episodes	 to	enable	comparisons	of	
the	 recordings	between	persons.	To	evaluate	 SWA	dissipation,	 the	difference	 in	
SWA	power	between	the	first	and	the	third	NREM	sleep	episodes	was	calculated.	
Artifacts were excluded by visual inspection and only artifact free epochs were 
included	in	the	power	spectral	analysis	(artifacts	comprised	on	average	1,6	%	of	the	
total	recording	time).	Repeated	measures	ANOVA	was	used	to	analyze	difference	
between	control	and	depressed	group	as	well	as	compare	SWA	power	in	different	
NREM sleep episodes and SWA dissipation. To assess relationship between SWA 
dissipation and severity of depression (evaluated by HDRS and BDI-21) Pearson 
correlation	coefficients	were	calculated.
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5. Results and Discussion
5.1. Exon-specific BDNF expression and methylation at different 
promoters during spontaneous sleep and after SD
Previous studies have established a role for BDNF as a regulator of sleep 
homeostasis. However, not much is known about epigenetic mechanisms of BDNF 
gene	 regulation	 during	 sleep.	 In	 this	 thesis,	 first	 I	 investigated	 the	 epigenetic	
mechanisms of BDNF gene expression during spontaneous sleep and SD in a rat 
model. By these means, I obtained additional information about the role of BDNF 
in sleep regulation. 
Increased number of  BDNF transcripts 1-4 and BDNF 9a has been shown after 
12	h	SD	in	genetically	modified	mice	(Martinowich	et	al.,	2011).		This	suggests	that	
BDNF	transcription	during	sleep	can	be	exon-specific	and	epigenetic	mechanisms	
might play an important role in BDNF regulation of sleep homeostasis.  
Three BDNF promoters, p1, p4 and p9, share similar features. All of them 
contain a Clock-controlled enhancer element E-box and are the most responsive to 
neuronal activity in vitro (Pruunsild et al., 2011). We studied the dynamic changes 
in these three BDNF transcripts’ expression and their promoters’ methylation 
levels in two brain regions involved in sleep regulation, BF and cortex, during the 
spontaneous sleep–wake cycle and after SD. We performed BDNF1, BDNF4 and 
BDNF9a expression and transcription-silencing 5-methylcytosine (5mC) DNA 
modification	analyses	in	rats	that	were	sleep-deprived	for	different	periods	of	time	
(3, 6 and 12 h) and in non-deprived rats.
5.1.1 BDNF1, BDNF4 and BDNF9a expression and DNA methylation in 
corresponding promoter regions during spontaneous sleep and after 
sleep deprivation in the basal forebrain
BDNF transcripts’ expression.	We	did	not	find	any	significant	changes	in	
daily oscillation of BDNF transcripts in non-deprived rats, instead SD upregulated 
both BDNF1 and BDNF4	 expression	 (main	 effect	 of	 SD	 on	 BDNF1 F1,23 = 8.38, 
P = 0.008 and BDNF4 F1,26 = 13.22, P = 0.001, Figure 8a). It should be noticed that 
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BNDF4	expression	was	affected	more	robustly	by	SD	compared	to	other	analyzed	
transcripts; its level was increased after 3 h SD and then returned to the level 
of	 the	 control	 non-deprived	 rats	 after	 12	 h	 SD	 (main	 effect	 of	 time	 F2,26 = 7.53, 
P = 0.003; interaction SD by time F2,26 = 6.54, P = 0.005). Similar activation of BDNF 
transcription	 after	 short-term	 SD	was	 found	 in	 different	 brain	 regions	 in	mice	
exposed to an acute restraint stress (Calabrese et al., 2009).
DNA methylation. Taking into account the total number of CpG 
dinucleotides that could be potentially detected as methylated in our MeDIP 
experiment (up to 25 CpG at p1, 18 CpG at p4 and 13 CpG at p9), the percentage 
of methylated cytosines at BDNF p1 was lower than at the other two promoters 
(Figure 8b). The 5mC levels at BDNF	promoters	were	not	affected	significantly	by	
time or SD factors (Figure 8b), although the amount of methylated cytosines at 
BDNF p1 was slightly increased after SD (F1,27 = 3.70, P = 0.065).
Association between BDNF transcripts’ expression and DNA 
methylation. To further study whether BDNF DNA methylation was associated 
with the levels of transcription driven from the corresponding promoters, a 
regression	 analysis	was	 performed.	We	 found	 a	 significant	 negative	 correlation	
between the BDNF1 transcript expression and DNA methylation level at the 
corresponding promoter in non-deprived rats (R = -0.713, F1,13 = 12.40, P = 0.004). 
After	SD	this	correlation	was	absent	(R	=	+0.15,	F1,14 = 0.30, P = 0.59; Figure 8c). No 
correlation for BDNF p4- or p9-driven transcription was found. 
Thus, we suggest that during spontaneous sleep–wake cycle, the changes in 
DNA methylation might contribute to BDNF1 transcription in rats, but they are not 
associated with BDNF4 and BNDF9a transcription in the BF.
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Figure 8. BDNF transcripts (a) and 5mC levels at the promoters BDNF p1, p4 and p9 (b) 
in the basal forebrain in the CTRL and SD groups. n = 4–6 rats per group. #P < 0.05 and 
0.09, P = 0.09 and 0.05, P = 0.05 in comparison with SD and the respective non-deprived 
CTRL	group;	*P	<	0.05,	**P	<	0.01	in	comparison	with	different	time-points	within	the	same	
treatment (CTRL or SD) groups. (c) Regression analysis of the BDNF1 transcript and p1 
DNA methylation levels; n = 14–15 rats per treatment. Reproduced from (Ventskovska et al., 
2015) with permission from the publisher.
5.1.2 BDNF1, BDNF4 and BDNF9a expression and DNA methylation in 
corresponding promoter regions during spontaneous sleep and after 
sleep deprivation in the cortex
BDNF transcripts’ expression. BDNF transcripts in the cortex were induced 
by SD. The most prominent changes were observed in BDNF1	expression	(main	effect	
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of SD F1,28 = 26.56, P < 0.0001). BDNF1	transcripts	were	significantly	upregulated	
after	3	h	SD	and	remained	elevated	throughout	the	SD,	reaching	a	10-fold	difference	
from	the	controls	after	12	h	SD.	This	finding	goes	in	line	with	previously	reported	
data	on	the	cortical	exon-specific	BDNF expression (Martinowich et al., 2011) and 
suggests that the BDNF	promoters’	structure	allows	high	flexibility	and	specificity	
to	respond	to	different	environmental	stimuli,	including	loss	of	sleep.
The expression of other transcripts was also elevated after SD but in smaller 
extent than BDNF1: for BDNF4 F1,28 = 10.47, P = 0.003 and for BDNF9a F1,28 = 3.29, 
P = 0.081 (Figure 9a). BDNF4 expression was upregulated throughout the SD. 
On the one hand, we observed a decrease in BDNF expression with increasing of 
SD duration that can be regarded as a down-regulation of BDNF in response to 
prolonged stress (Roceri et al., 2004). However, on the other hand, there was a 
significant	effect	of	 the	time	 factor	on	the	decrease	 in	BDNF4 levels (F2,28 = 4.11, 
P = 0.027), which can represent a diurnal variation in its expression.
DNA methylation. The percentage of methylated cytosines at the promoter 
BDNF p1 demonstrated daytime regulation: methylation level at this promoter 
decreased		significantly	by	the	end	of	the	light	phase	(ZT12,	CTRL	group	12	h)	in	
non-deprived rats, whereas such regulation was absent in SD rats (Figure 9b). The 
daytime 5mC changes were not observed at the promoter BDNF p4 in non-deprived 
CTRL	rats,	but	there	was	a	trend	for	the	main	effect	of	SD	on	decrease	in	BDNF p4 
methylation (F1,26 =	3.46,	P	=	0.074)	with	a	significant	decrease	after	12	h	SD.	The	
5mC levels at BDNF p9 promoter were decreased at ZT12 time independently of SD 
treatment	(main	effect	of	time	F2,27 = 7.03, P = 0.0035). 
Association between BDNF transcripts’ expression and DNA 
methylation.	The	regression	analysis	revealed	a	significant	negative	correlation	
between the BDNF9a expression and 5mC levels at BDNF p9 in non-deprived rats 
(R = 0.558, F1,16 = 6.79, P = 0.02). But this correlation was not observed in SD rats 
(R	=	+0.042,	F1,14 = 0.02, P = 0.88; Figure 9c). 
Thus, in the cortex, DNA methylation was not associated with the SD-
induced BDNF1 expression but was associated with the BDNF9a levels in CTRL 
non-deprived rats and, possibly, with the BDNF4 levels at the 12-h time-point.
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Figure 9. BDNF transcripts (a) and 5mC levels at the promoters BDNF p1, p4 and p9 (b) 
in the cortex in the CTRL and SD groups. n = 4–6 rats per group. #P < 0.05, ##P < 0.01 
and 0.08, P = 0.08 in comparison with the SD and respective CTRL non-deprived groups; 
*P	<	0.05,	**P	<	0.01	in	comparison	with	different	time-points	within	the	same	treatment	
(CTRL or SD) groups. (c) Regression analysis of the BDNF9a transcript and p9 DNA 
methylation levels; n = 15–17 rats per treatment. Reproduced from (Ventskovska et al., 2015) 
with permission from the publisher.
SD effects.	We	demonstrated	for	the	first	time	that	in	two	interconnected	
brain areas crucial for sleep regulation (BF and frontal cortex) the magnitude and 
dynamics of SD-induced BDNF up-regulation were transcript- and brain area-
dependent. SD led to the robust but transient BDNF4 up-regulation in the BF 
and persistently strong BDNF1 up-regulation in the cortex. However, regression 
analysis	between	different	BDNF transcripts’ expression and DNA methylation in 
corresponding	promoters	did	not	reveal	a	significant	correlation	in	SD	rats.	
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Interestingly, short-term SD rapidly induced BDNF transcription; the 
highest BDNF1 levels in the BF and BDNF4 levels in both brain areas were observed 
already	after	3	h	SD.	Similar	to	this	finding,	fast	and	transient	increase	of	BDNF 
mRNA	levels	was	observed	in	different	brain	regions	(e.g.	hippocampus,	prefrontal	
and cingulate cortex) in rats exposed to an acute restraint stress (Calabrese et al., 
2009).	Although	the	effect	of	stress	in	our	experiments	was	minimized	by	handling	
the animals before the experiments and using gentle technique of SD, BDNF up-
regulation	may	indicate	the	necessity	of	activation	of	different	neuronal	plasticity-
related genes in response to acute stress (Calabrese et al., 2009). With increasing of 
SD duration we observed decrease in BDNF expression, which is known as down-
regulation of BDNF in response to prolonged stress and was shown in repeated 
maternal deprivation experiments (Roceri et al., 2004).
Diurnal variations. We found a daily variation in BDNF levels in non-deprived 
rats: the highest BDNF1 expression after 6 h of rest phase and the lowest BDNF4 
levels after 12 h of rest phase in the cortex. Diurnal BDNF variation was also found 
previously in the hippocampus, where the lowest BDNF1 and BDNF4 levels were seen 
after 6 h of rest phase (Berchtold et al., 1999). We think that transient increase in 
BDNF1 expression	may	reflect	the	ongoing,	 local	plasticity	processes	during	sleep,	
whereas decrease in BDNF4 expression	 after	 12	 h	 of	 rest	 period	may	 reflect	 the	
involvement of BDNF in regulation of sleep homeostasis (Porkka-Heiskanen, 2013). 
Regression	analysis	between	different	BDNF transcripts’ expression and DNA 
methylation in corresponding promoters revealed a negative correlation only for the 
control non-deprived rats: in the BF for BDNF1, and in the cortex for BDNF9a. It is 
known that DNA methylation is implicated in circadian regulation of mammalian 
Clock-related gene expression (Satou et al., 2013). Moreover, recently it has been 
shown	 in	 mice	 that	 changing	 of	 light	 conditions	 alters	 gene	 expression	 profiles	
and promoter DNA methylation in the SCN, thus it has been suggested that DNA 
methylation might be a mechanism driving circadian clock plasticity in mammals 
(Azzi	 et	 al.,	 2014).	 	 In	 the	 present	 study	we	 showed	 for	 the	 first	 time	 that	DNA	
methylation is also involved in diurnal regulation of non-Clock genes, such as BDNF.
Thus, we showed that the modulation of BDNF transcription during 
spontaneous	sleep-wake	cycle	 is	at	 least	partially	regulated	by	brain	site	specific	
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DNA methylation. Further research is needed to understand the complexity of 
epigenetic regulation involved in diurnal regulation of BDNF expression.
The fact that no associations were found between the 5mC and mRNA levels in 
sleep deprived rats suggests that SD could disturb the normal epigenetic control of 
BDNF expression, implicating other regulatory mechanisms of BDNF transcription 
(e.g.	5-hydroxymethylcytosine	DNA	modification,	histone	modifications).
5.2. Effect of cross-fostering on sleep, BDNF gene expression 
and behaviour in rats
Adversities experienced during early periods of life, such as childhood and 
adolescence, have been associated with early-onset depression (Arnow, 2004). 
Both of these age periods are extremely important for future mental wellbeing 
and are vulnerable to environmental conditions. The exact mechanisms by which 
environmental	stimuli	affect	future	development	have	been	the	subject	of	many	
studies but still remain poorly understood. BDNF appears to be a good candidate 
for	mediating	short-	and	long-term	effects	of	early	life	stress	experience	on	brain	
function later in adulthood.
So, we studied the molecular level mechanisms by which the early life stress 
modifies	 sleep	 by	using	animal	model	 (cross-fostering)	 (Study	 II).	This	model	 is	
based on changing the pups between mothers at early age. CF may satisfyingly model 
stressful life events in human childhood and it demonstrates the critical role of the 
postnatal	maternal	environment	in	programming	the	offspring’s	development.
5.2.1 Spontaneous sleep, sleep homeostasis and adenosine in adult cross-
fostered rats
Cross-fostering procedure led to increased total time spent in NREM sleep (F2,273 
= 4.14, P = 0.04) and REM sleep (F2,273 = 7.17, P = 0.008) and decreased time in waking 
(F2,273 = 4.77, P = 0.03) compared to CTRL rats during light period of the day (Figure 10A). 
In	addition,	a	difference	in	REM	sleep	parameters	between	sexes	was	observed	
(for REM duration: F2,273 = 35.28, P < 0.001; for REM episodes onsets: F2,273 = 16.67, 
P < 0.001). Individual one-way ANOVA within the same-sex group revealed that 
REM	sleep	duration	in	CF	females	was	significantly	longer	than	in	CTRL	females	
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(F1,118	 =	 4.1,	 P	 =	 0.04),	 while	 in	 CF	 males	 there	 was	 no	 statistically	 significant	
difference,	although	there	was	observed	the	same	tendency	(F1,153 = 3.35, P = 0.07). 
Both CF male and female rats also had higher number of REM sleep onsets 
than CTRL rats (F2,273 = 18.5, P < 0.001) during the light period (Figure 10B). 
During the dark period, CF rats tended to have longer NREM sleep duration 
(F2,273 =	3.46,	P	=	0.06)	(Figure	10A)	and	had	significantly	higher	number	of	REM	
sleep onsets (F2,273 = 5.32, P = 0.032) compared to CTRL rats (Figure 10B). It should 
be	noted	that	individual	analysis	of	main	effect	of	CF	within	the	same-sex	group	
revealed	 that	 the	 number	 of	 REM	 sleep	 onsets	 was	 significantly	 higher	 in	 CF	
females compared to CTRL females (F1,118 = 5.56, P = 0.02), but was similar between 
CF and CTRL males (F1,154 = 0.8, P = 0.37) (Figure 10B).
Figure 10. (A) Distribution of the vigilance states through light-dark period and (B) number 
of REM sleep episode onsets in CTRL and CF male and female rats during spontaneous sleep 
(BL day). Males (n=7/control group, n=6/CF group), females (n=5/CTRL group, n=5/CF 
group).	#	–	P	<	0.05,	difference	is	significant	between	CTRL	and	CF	rats	(factorial	ANOVA	
(factors:	sex	and	treatment),	*	–	P	<	0.05,	difference	is	significant	between	CTRL	and	CF	
rats within same-sex group (one-way ANOVA), CTRL: control rats, CF: cross-fostering rats, 
BL:	baseline	day.	Modified	from	Study	II.
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Previously, it has been shown that early life stress, particularly maternal 
separation,	has	an	effect	on	spontaneous	sleep	in	adulthood:	increases	in	different	
parameters of REM sleep (Sampath et al., 2014; Tiba et al., 2004); some studies 
have reported also decrease in REM sleep (Perez-Morales et al., 2014; Reyes Prieto 
et al., 2012). Changes in NREM sleep have also been reported (Mrdalj et al., 2013; 
Perez-Morales et al., 2014; Reyes Prieto et al., 2012; Sampath et al., 2014). Our 
results, indicating more time spent in NREM and REM sleep by CF rats are in line 
with many previous studies, although the CF model deviates from the maternal 
separation.
Higher number of REM sleep onsets during spontaneous sleep in CF treated 
rats was the most prominent change in sleep pattern observed in our study. 
Sleep disturbances and particularly disinhibition of REM sleep is one of the core 
symptoms of depression in humans (Adrien, 2002; Fleming, 1994), which has its 
equivalent in rats (Schmidt et al., 2011), indicating that the CF model may be a 
useful animal model of depression. 
Adenosine, produced in BF, is an important regulator of sleep homeostasis 
(Basheer et al., 2004; Porkka-Heiskanen et al., 1997). We measured its amount 
during	 inactive	phase	of	BL	day	and	 found	 that	 its	 level	was	significantly	 lower	
in both male (F1,128 = 6.47, P = 0.012) and female (F1,66 = 7.44, P = 0.008) CF rats 
compared to CTRLs (Figure 11). We suggest that the low adenosine level in BF could 
contribute to the sleep changes observed in the adult CF rats. Decreased adenosine 
level in this area has been observed in other animal models of depression (Savelyev 
et al., 2012), and a role for low adenosine level has been previously suggested in 
development of depressive disorder (Gass et al., 2010; Hanson, 2009; Kaster et al., 
2004). 
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Figure 11. Adenosine concentration (nM) during BL day (09:30 AM–08:30 PM) in CTRL 
and CF male and female rats in the basal forebrain. Males: n=7/CTRL group, n=6/CF group, 
females: n=5/CTRL group, n=5/CF group. *	–	P	<	0.05,	difference	 is	significant	between	
CTRL and CF rats within same-sex group (one-way ANOVA). CTRL: control rats, CF: cross-
fostering	rats,	BF:	basal	forebrain,	BL:	baseline.	Modified	from	Study	II.
To	study	whether	sleep	homeostasis	is	affected	in	CF	rats,	we	performed	3h	
SD during the light period of the day (1 PM – 4 PM) and analysed recovery sleep (4 
PM – 9 PM). Factorial repeated measures ANOVA showed that SD led to normal 
homeostatic response in all rats. Total NREM sleep duration was increased after SD 
compared to respective baseline period (F1,20 = 35.50, P < 0.001) in both CTRL and 
CF rats irrespective of sex (Figure 12A).
For	REM	sleep,	 factorial	 repeated	measures	ANOVA	revealed	a	significant	
effect	of	sex	and	treatment,	with	significant	interactions	between	SD	and	sex,	and	
between	SD	and	 treatment.	The	effect	of	 SD	did	not	 reach	 level	of	significance	
(F1,20 = 3.93, P = 0.06). Males had longer REM sleep duration than females during 
spontaneous sleep, but shorter during recovery period (F1,20 = 10.96, P = 0.003, the 
interaction F1,20 = 28.88, P < 0.001). CF rats had longer REM sleep duration than 
CTRL rats during spontaneous sleep (F1,20 = 6.72, P = 0.02) but its duration was 
equal during the recovery period (the interaction F1,20 = 4.96, P = 0.04).
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Figure 12. (A) NREM and (B) REM sleep duration in CTRL and CF male and female rats 
during recovery period (4 PM - 9 PM) after SD. Males (n=7/control group, n=6/CF group), 
females	(n=5/CTRL	group,	n=5/CF	group).	#	–	P	<	0.05,	difference	is	significant	between	BL	
and SD days, when the post-SD recovery sleep was compared to the corresponding hours of 
BL day (factorial repeated measures ANOVA (between subject factors: sex and treatment, 
within-subject	factor:	SD).	*	–	P	<	0.05,	difference	is	significant	between	BL	and	SD	days	
within same–sex, same-treatment group (one-way ANOVA). CTRL: control rats. CF: cross-
fostering	rats,	BL:	baseline	day,	SD:	sleep	deprivation.	Modified	from	Study	II.
Individual one-way ANOVA within same-sex and same-treatment group 
revealed that REM sleep duration was decreased in CF males after SD (F1,5 = 20.17, 
P = 0.006) compared to respective hours of BL day; in CTRL males, no changes of 
REM sleep duration were found. CTRL females demonstrated higher REM sleep 
duration after SD (F1,4 = 11.10, P = 0.03), but not CF females (Figure 12B).
One of the most powerful sleep homeostasis marker is EEG delta power 
in NREM sleep (Borbely & Achermann, 1999). We calculated NREM sleep delta 
power (1.08-3.79 Hz) during one hour of post-SD recovery period (4 PM - 5 PM) 
and	 found	 that	all	 rats	demonstrated	significant	 increase	 in	delta	power	during	
the recovery sleep (F1,20 = 88.392, P < 0.001) irrespective of treatment (CF vs. CTRL) 
(Figure	13).	This	indicates	that	homeostatic	sleep	regulation	was	not	significantly	
impaired in CF rats. Sleep deprivation for 3 h is considered a minimum time to 
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induce increased NREM sleep duration and intensity, as well as in elevated BF 
adenosine level (Kalinchuk et al., 2006; Savelyev et al., 2012).
Figure 13. NREM sleep delta (1.08-3.79 Hz) power in CTRL and CF male and female rats 
during one-hour recovery sleep (4 PM -5 PM) after SD. Delta power during corresponding 
time	 (4	 PM	 -5	 PM)	during	 BL	day	was	used	as	 a	 reference	value	of	 100%.	Males	 (n=7/
control group, n=6/CF group), females (n=5/CTRL group, n=5/CF group). While there is 
a	significant	 increase	(P	<	0.05)	 in	NREM	sleep	delta	power	after	SD	(factorial	repeated	
measures ANOVA (between subject factors: sex and treatment, within-subject factor: 
SD)	for	both	females	and	males	(about	50%	and	20%,	respectively),	there	is	no	difference	
between CTRL and CF rats. CTRL: control rats. CF: cross-fostering rats, BL: baseline day, 
SD:	sleep	deprivation.	Modified	from	Study	II.
5.2.2 Effect of cross-fostering treatment on BDNF gene expression in 
adolescence and adulthood
BDNF is one of the main neuroplasticity molecules, which is known to 
be involved in both sleep regulation and depression development (Castren & 
Rantamaki, 2010; Dwivedi, 2009; Faraguna et al., 2008). We measured the BDNF 
expression levels in males and females at two time points: during adolescence 
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(PND 50) and adulthood (PND 110). The measurements were done in three brain 
regions: basal forebrain, frontal cortex, and hypothalamus.
Factorial	 ANOVA	 yielded	 significant	 main	 effects	 for	 age	 and	 treatment	
factors	in	BF,	but	not	for	sex	factor.	No	differences	were	found	in	other	brain	areas.
Rats demonstrated higher BDNF gene expression during adolescence 
compared to adulthood (F3,41 = 7.75, P = 0.009), and CF rats tended to have lower 
BDNF gene expression compared to CTRLs (F3,41 = 3.17, P = 0.08) (Figure 14).
Figure 14. BDNF gene expression in the basal forebrain, frontal cortex and hypothalamus 
in male and female rats during adolescence and adulthood. Males: n=5/CTRL group, n=6/
CF group, females: n=6/CTRL group, n=6/CF group. In the basal forebrain, BDNF gene 
expression level was higher in adolescence than in adulthood (factorial ANOVA (factors: 
sex, age and treatment), P < 0.05) and tended to be lower in CF rats than in CTRLs (factorial 
ANOVA	(factors:	sex,	age	and	treatment),	P	=	0.08).	The	differences	were	not	observed	in	
other	brain	areas.	CTRL:	control	rats,	CF:	cross-fostering	rats,	ACTB:	actin	beta.	Modified	
from Study II.
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Age-dependent changes in BDNF gene expression have been detected before 
in hippocampus (decreasing with age) and medial prefrontal cortex (increasing 
with	age)	(Wang	et	al.,	2015).	To	our	knowledge,	this	study	is	the	first	to	investigate	
changes in BDNF gene expression in the BF with age. Previously (Wang et al., 
2015),	 it	has	been	shown	that	maternal	separation	differently	affects	BDNF gene 
expression in individual brain regions: increases in hippocampus and decreases 
in medial prefrontal cortex. In another study, the down-regulation of BDNF 
expression was shown only in prefrontal cortex, but not in hippocampus (Roceri et 
al.,	2004).	We	did	not	find	any	significant	difference	between	CTRLs	and	CF	rats	in	
any of the studied brain regions (frontal cortex or hypothalamus) beside tendency 
to lower gene expression in CF rats compared to CTRLs in BF. We hypothesize that 
this trend in BDNF	expression	observed	in	the	BF,	may	reflect	dysfunction	of	the	
cholinergic neurotransmission that may account for the development of cognitive 
impairment often associated with psychopathologies (Dagyte et al., 2011) and 
usually observed in cognitive tests. 
5.2.3 Effect of cross-fostering treatment on behaviour and body weight in 
adolescence and adulthood
To assess anxiety and depression-like behaviour in CF rats, we performed 
two behavioural tests: OF test (in adolescence, at PND 45, and in adulthood, at 
PND 100) and SPT in adulthood only, at PND 105. 
Open	 field	 test	 is	 widely	 used	 to	 assess	 general	 locomotor	 activity,	
emotionality, and exploratory behaviour in rodents. Horizontal (number of 
squares crossed in inner and outer areas) and vertical activities (rearings) are used 
as measures of exploration behaviour. At the same time, activity in the central 
vs.	peripheral	sectors	reflects	the	proportion	between	exploratory	behaviour	and	
harm avoidance, respectively (Archer, 1973; Redina et al., 2009). The number of 
defecations and urinations is used as indicator of sympathetic nervous activity 
(Archer, 1973). All these parameters taken together give an estimate of the anxiety 
level of the animal.
In	 the	 OF	 test,	 factorial	 ANOVA	 yielded	 a	 significant	 effect	 of	 sex	 on	 3	
parameters,	and	significant	effect	of	age	on	5	parameters,	but	no	significant	effect	
of CF treatment was found in any studied parameter of the OF test.
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The number of defecations was higher in males (F3,137 = 24.93, P < 0.001) 
compared to females (Table 3, 4). Females had higher number of squares crossed 
in outer area (F3,137 = 10.51, P = 0.001) and total number of squares crossed (F3,137 = 
9.02, P = 0.002) compared to males. Moreover, the number of squares crossed in 
outer area (F3,137 = 14.07, P < 0.001), the total number of squares crossed (F3,137 = 14.34, 
P < 0.001), grooming number (F3,137 = 24.17, P < 0.001) and duration (F3,137 = 17.46, P 
< 0.001), and defecation number (F3,137 = 6.3, P = 0.013) decreased with age (Table 3, 
4). The interaction between sex and age was observed for defecation number (F6,134 
= 9.32, P = 0.003).
Table 3. Effect of CF on behaviour in the OF test in adolescent and adult male rats
 Adolescence Adulthood
Behavioural parameters CTRL CF CTRL CF
Horizontal activity    
Latency to leave the central area, s 3.9±0.4 4.7±0.8 7.2±2.6 5.2±1.2
Number of squares crossed in the inner area 5.4±1.2 2.5±0.8 1.4±0.3 1.8±0.5
Number of squares crossed in the outer area 68.1±6.0 62.4±6.3 40.1±5.5& 46.4±4.9&
Total number of squares crossed 73.3±6.3 65.0±6.5 41.7±5.5& 48.2±5.0&
Vertical activity  
Rearing number 13.8±2.4 8.7±1.7 6.0±1.4& 4.3±0.9&
Grooming  
Latency of grooming, s 146.5±28.1 133.3±24.5 203.5±18.5 141.5±3.5
Grooming  episodes number 0.4±0.1 0.5±0.1 0.1±0.1& 0.2±0.2&
Total grooming duration, s 5.1±2.2 5.6±2.3 1.5±1.1& 0.7±0.5&
Excretory activity  
Defecation number 2.8±0.5 3.9±0.5 3.1±0.6& 3.7±0.7&
Urination number 2.5±0.6 2.1±0.6 2.6±0.6 2.5±0.4
Values	represent	mean	±	SEM;	&	–	difference	is	significant	between	two	age	groups	(adolescence	vs.	
adulthood, P < 0.05). Adolescence: n=22/CTRL group, n=21/CF group, adulthood: n=18/CTRL group, 
n=14/CF	group.	OF:	open	field;	CTRL:	control	rats;	CF:	cross-fostered	rats.	Modified	from	Study	II.
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Table 4. Effect of CF on behaviour in the OF test in adolescent and adult female rats
 Adolescence Adulthood
Behavioural parameters CTRL CF CTRL CF
Horizontal activity    
Latency to leave the central area, s 4.6±0.6 6.9±2.1 5.1±1.3 4.5±0.8
Number of squares crossed in the inner area 2.9±0.6 3.2±0.5 1.9±0.3 4.3±1.0
Number of squares crossed in the outer area 78.4±6.2 70.7±5.4 55.2±5.1& 69.4±5.5&
Total number of squares crossed 81.3±6.4 73.9±5.6 57.1±5.2& 73.7±6.1&
Vertical activity  
Rearing number 10.8±1.5 9.4±1.3 9.1±2.0 13.9±2.3
Grooming  
Latency of grooming, s 118.6±14.5 136.5±11.6 - -
Grooming  episodes number 0.5±0.1 0.8±0.1 - -
Total grooming duration, s 5.7±2.2 9.0±2.2 - -
Excretory activity  
Defecation number 1.9±0.6 3.0±0.3 0.2±1.1& 0.5±0.3&
Urination number 2.6±0.6 3.0±0.5 2.1±0.9 1.8±0.3
Values	represent	mean	±	SEM;	&	–	difference	is	significant	between	two	age	groups	(adolescence	vs.	
adulthood, P < 0.05). Adolescence: n=14/CTRL group, n=24/CF group, adulthood: n=9/CTRL group, 
n=19/CF	group.	OF:	open	field;	CTRL:	control	rats;	CF:	cross-fostered	rats.	Modified	from	Study	II.
Thus,	we	 concluded	 that	 the	 activity	 of	 CF	 rats	 in	OF	 test	 did	 not	 differ	
significantly	from	the	activity	of	CTRL	rats	in	any	of	the	studied	parameters.	
To test the depressive-like behaviour, we performed SPT, which is used in 
rodent experiments as a measure of sensitivity to reward (Harris et al., 1997) and 
anhedonia (Castagne et al., 2009; Willner et al., 1987). It has been shown previously 
in	different	animal	models	of	depression	that	sucrose	intake	is	significantly	reduced	
in animals with depressive-like behaviour as compared to controls (Goshen et al., 
2008; Grippo et al., 2005; Rygula et al., 2005; Savelyev et al., 2012).
We performed factorial ANOVA to assess the sucrose consumption in our 
rats,	and	it	revealed	no	significant	effect	of	CF	treatment	(F2,54 = 1.74, P = 0.19), sex 
(F2,54 = 0.05, P = 0.83), or interaction (F2,53 = 1.39, P = 0.24) between them (Figure 15).
Taking together the results from behaviour tests, we conclude that CF rats 
did not demonstrate anxiety or depressive-like behaviour under normal conditions 
and their behaviour was similar to the sex-and age-matched control rats. However, 
taking into account the molecular level changes after CF reported above, it can be 
suggested that under stressful conditions, brain resilience could be compromised, 
and behavioural changes would be observed. 
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Figure 15.	Effect	of	CF	on	sucrose	preference	in	adulthood	in	males	and	females.	Males:	
n=18/CTRL group, n=13/CF group, females: n=8/CTRL group, n=18/CF group. CTRL: 
control rats, CF: cross-fostered rats, SPT: sucrose preference test.
Along with behavioural indices, we also assessed weight of the rats. Factorial 
ANOVA	 revealed	 statistically	 significant	 effect	 of	 all	 the	 factors:	 sex,	 age,	 and	
treatment on weight of the animals.
The	body	weight	was	significantly	higher	in	males	compared	to	females	(F3,110 
= 99.99, P < 0.001), and in adulthood compared to adolescence (F3,110 = 562.21, P < 
0.001)	(Table	5).		The	interaction	between	sex	and	age	was	significant	(F3,107 = 172.98, 
P	<	0.001).	The	effect	of	CF	treatment	was	significant	(F3,110 = 4.11, P = 0.04). 
Adolescent CF males had lower weight than CTRLs (F1,26 = 5.63, P = 0.03), but 
in	adulthood	this	difference	faded	away	(F1,30 = 0.46, P = 0.5), whereas CF females 
had lower body mass during both age periods: adolescence (F1,25 = 15.79, P = 0.001) 
and adulthood (F1,25 = 4.61, P = 0.04) (Table 5).
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Table 5. Effect of CF on body weight in male and female rats during adolescence and 
adulthood
Treatment
groups
Adolescence 
(weight, g)
Sample size,  
n
Adulthood 
(weight, g)
Sample size,  
n 
Males
CTRL 134.7±5,8 13 309.1±7.6& 18
CF 117.7±4,4* 15 302.4±5.1& 14
Females
CTRL 130.7±2.8 6 203.9±2.7& 9
CF 106.9±3.1* 21 197.9±1.5*& 18
Values	represent	mean	±	SEM.	*-	difference	is	significant	between	CTRL	and	CF	groups	within	same-
sex, same-age group (P < 0.05); &	–	difference	is	significant	between	two	age	groups	(P	<	0.05). CTRL: 
control	rats;	CF:	cross-fostered	rats.	Modified	from	Study	II.
Thus, both male and female CF rats had lower body weight in adolescence 
compared to CTRL rats, which is in line with previous studies on rodent models of 
depression (Willner, 2017). In adulthood only female CF rats demonstrated lower 
body weight compared to CTRLs. However, it should be noted that although the 
difference	was	statistically	significant	the	real	difference	in	weight	between	CF	and	
CTRL adult female was rather small.
5.3. Sleep and slow-wave activity in early-onset depression
To evaluate what sleep changes occur in early-onset depression in humans, 
we assessed sleep macro- and micro-architecture in a clinical sample of depressed 
adolescent boys in Study III.
5.3.1 Sleep architecture in depressed adolescent boys
All participants underwent detailed clinical and psychiatric evaluation 
and 8 of them were diagnosed with depressive disorder according to the DSM-IV 
criteria; among age-matched controls no axis-I diagnoses were found. The details 
of psychiatric evaluation are presented in the table 6. 
71
Table 6. Details of clinical and psychiatric evaluation in the study participants
Variable Controls Patients
Age 16.2 ± 0.7 (14.8-17.2) 16.9 ± 1 (14.7-17.3)
BMI 20.6 ± 1.7 (17.8-23.8) 16.9 ± 3.9 (16.8-27.6)
S-Testo 19.4 ± 3.6 (15.3-27.6) 16.9 ± 4.1 (15.0-26.3)
BDI-21 2.8 ± 4.0 (0-12) 16.9 ± 12.0 (1-33) *
HDRS 0.3 ± 0.7 (0-2) 12.9 ± 4.4 (7-19) **
AIS 2.1 ± 2.2(0-7) 9.4 ± 6.2 (1-18) *
Data	are	 reported	as	mean	 ±	 SD	 (range).	 Significant	differences	 between	controls	 and	depressed	
patients are marked with asterisks (*p<0.05, **p<0.001). Controls: n= 10, patients: n=8. BMI, Body 
Mass Index; S-Testo, serum testosterone level (nmol/l; n=9 for controls); BDI-21: 21-item Beck 
Depression Inventory; HDRS: Hamilton Depression Rating Scale; AIS: Athens insomnia scale. 
Modified	from	Study	III.
Sleep was recorded in subjects’ home environment during two consecutive 
nights. First night served as an adaptation night and recordings during the second 
night	were	used	for	assessing	sleep	macroarchitecture.	Different	sleep	parameters	
(presented	in	the	table	7)	were	evaluated.	 	No	significant	differences	in	assessed	
parameters	between	patients	suffering	from	depression	and	controls	were	found,	
beside shorter TST in the group of patients (F1,15=6.61, p=0.02).
Table 7. Sleep parameters in control and depressed adolescents
Sleep parameters Controls Patients
TST, min* 481.05 ± 11.84 426.57 ± 25.40
Sleep	efficiency 97.15 ± 0.96 93.81 ± 3.42
N1,	% 4.00 ± 0.84 4.86 ± 0.80
N2,	% 51.68 ± 1.31 49.27 ± 2.71
N3,	% 27.47 ± 1.79 29.30 ± 3.77
REM,	% 16.86 ± 1.93 16.56 ± 2.20
SWS latency, min 14.85 ± 2.66 35.79 ± 17.56
REM sleep latency, min 151.35 ± 17.26 113.50 ± 22.09
Awakenings, number 11.40 ± 2.50 8.00 ± 1.68
Data	 are	 reported	 as	 mean	 ±	 SEM.	 Significant	 difference	 between	 control	 group	 and	 depressed	
patients group *p<0.05 (ANOVA). Controls: n=10, patients: n= 8. TST: total sleep time; N: NREM 
sleep	stage;	REM:	rapid	eye	movement	sleep;	SWS:	slow-wave	sleep.	Modified	from	Study	III.
The	shorter	TST	observed	in	the	group	of	depressed	adolescents	may	reflect	
such	insomnia	symptoms	as	difficulties	in	falling	asleep,	disrupted	sleep	continuity,	
and early morning awakenings that are very common for depressive disorder 
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(Steiger & Kimura, 2010). This is also evidenced by higher AIS scores found in our 
study in depressed boys compared to controls. 
5.3.2 SWA power, dissipation and rise rate in depressed adolescent boys 
Slow wave sleep with its typical SWA, is the most restorative stage of sleep 
(Akerstedt et al., 1997; Dijk, 2009). Temporal distribution of SWA through the 
night is considered to be a principal physiological marker of sleep homeostatic 
regulation (process S) (Borbely & Achermann, 1999). To assess sleep homeostasis in 
depressed boys, we calculated SWA delta power, its temporal distribution through 
the	night	(dissipation)	and	rise	rate	during	the	first	NREM	episode,	and	compared	
these parameters to the values found in the control group. 
Across all individuals, we observed similar pattern with highest SWA in the 
first	NREM	and	smallest	in	the	third	NREM	episode	(F2,32=22.06, p<0.001), which is 
the normal course of spontaneous sleep, when the highest SWA is observed in the 
beginning of the night and then gradually declines towards the end of the night 
(Dijk, 2009). Moreover, all individuals had higher SWA values in frontal derivation 
as compared to central one (F1,16=63.49, p<0.001). 
We	found	that	SWA	in	depressed	patients	was	lower	during	the	first	NREM	
episode in the frontal derivation (F1,16=6.8, p=0.02) and higher during the third 
NREM episode in the central derivation (F1,16=5.37, p=0.03) as compared to healthy 
subjects (Figure 16). 
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Figure 16.	SWA	power	in	frontal	(A)	and	central	(B)	EEG	derivations	in	first	three	NREM	
sleep episodes. Controls: n=10, patients: n= 8. Data are illustrated as mean ± SEM. Repeated 
measures ANOVA (within-subject factors: derivation and NREM episode, between-subject 
factor: group), *p<0.05. SWA: slow-wave activity; EEG: electroencephalogram; NREM: 
non-rapid	eye	movement	sleep.	Modified	from	Study	III.
To assess the dissipation pattern of SWA through the night, we estimated 
the	decline	of	SWA	from	the	first	 to	the	third	NREM	episode	and	 found	that	 it	
was more prominent in the group of healthy subjects as compared to depressed 
patients (F1,16=5.21, p=0.04) and in the frontal derivation as compared to the central 
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derivation (F1,16=30.93,	p<0.001).	 In	the	frontal	derivation,	the	difference	 in	SWA	
power	between	the	first	and	the	third	NREM	episode	was	significantly	smaller	in	
depressed patients compared to healthy controls (F1,16=5.32, p=0.04); in the central 
derivation it tended to be smaller (F1,16=4.09, p=0.06) (Figure 17). 
* �
Figure 17.	Decline	of	SWA	power	from	the	first	to	the	third	NREM	episode	in	frontal	and	
central EEG derivations. Controls: n=10, patients: n=8. Data are illustrated as mean ± SEM. 
Repeated measures ANOVA (within-subject factors: derivation, between-subject factor: 
group), *p<0.05, #p=0.06. SWA: slow-wave activity; EEG: electroencephalogram; NREM: 
non-rapid	eye	movement	sleep.	Modified	from	Study	III.
Lower	SWA	power	 in	the	first	NREM	episode	and	smaller	decline	of	SWA	
in the course of sleep found in the group of depressed patients indicate a more 
evenly distributed SWA power through the night in depressed patients compared 
to healthy subjects. These observations are in line with earlier studies in adults 
(Argyropoulos & Wilson, 2005; Armitage, 2007) and adolescents (Armitage et al., 
2001; Lopez et al., 2012), showing that depressed patients have lower SWA power in 
the	first	NREM	sleep	episode	and	an	irregular	SWA	dissipation	pattern	compared	
to healthy individuals. Moreover, lower SWA power observed in depressed patients 
compared	to	healthy	subjects	can	be	also	associated	with	different	physical	and	
mental activities during preceding wake period. It has been recently shown in 
animal and human studies that sensory stimulation, physical exercise and learning 
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during preceding wake period can locally increase SWA in involved brain areas 
(Huber et al., 2004; Vyazovskiy et al., 2000; Vyazovskiy et al., 2006). This is in 
line with the synaptic homeostasis hypothesis of sleep, postulating that synaptic 
downscaling occurring during sleep selectively favours strengthening of those 
synaptic connections that were used most during preceding wakefulness (Tononi 
& Cirelli, 2003). Actigraphic study performed in the same sample of depressed 
adolescent boys (Merikanto et al., 2017) demonstrated lower activity levels in 
depressed boys compared to healthy subjects, especially on weekends. Thus, it can 
be	 suggested	 that	 the	difference	 in	 SWA	power	 between	depressed	and	control	
subjects	can	be	at	least	partially	associated	with	different	activity	levels	during	wake	
periods preceding EEG recordings. However, additional experiments to clarify this 
issue should be performed, including brief questionnaires evaluating mental and 
physical activity of the subjects. 
We found that in the central derivation SWA in depressed adolescents 
remained at a higher level after three NREM episodes as compared to healthy 
controls. This may be interpreted as a partially incomplete dissipation of SWA, 
which means that the core restorative process of sleep is unsuccessful and part of 
sleep pressure remains. This resembles the sleep deprivation-like state in healthy 
individuals,	 which	 is	 known	 to	 affect	 mood	 and	 performance	 (Alhola	 &	 Polo-
Kantola, 2007; Simon et al., 2015). However, it should be noted that in our study 
SWA	was	assessed	only	during	the	first	three	NREM	episodes,	since	all	the	subjects	
had at least three NREM episodes during the night; but some of the participants 
had	four	(or	sometimes	even	five)	episodes	of	NREM	in	total.	It	is	therefore	possible	
that during the following episodes the levels of SWA in controls and depressed 
subjects reached the same level. To verify this assumption a bigger sample size is 
needed to be able to match control and depressed participants by the number of 
NREM episodes during the night.
Another marker of sleep homeostatic regulation is a rise rate of SWA during 
the initial stage of sleep (Dijk et al., 1990), which is calculated during the initial 
stages	of	sleep.	We	found	that	during	the	 initial	 10	min	of	the	first	NREM	sleep	
episode depressed patients demonstrated slower buildup of SWA compared 
to healthy subjects in the frontal derivation (p=0.03), but not in the central one 
(p=0.16).
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In summary, depressed adolescent boys had lower SWA power and its slower 
rise	in	the	course	of	the	first	NREM	episode,	and	a	flatter	SWA	dissipation	through	
the night in frontal area as compared to healthy boys. These results indicate that 
homeostatic sleep regulation may be impaired in adolescent depression patients. 
Indeed,	 according	 to	 the	 S-deficiency	 hypothesis	 of	 depression	 (Borbely	 &	
Wirz-Justice, 1982), homeostatic sleep regulation is impaired in depression and 
depressed	 individuals	 fail	 to	accumulate	a	sufficient	sleep	drive	during	daytime.	
Sleep	deprivation	 is	 considered	an	efficient	 (but	 short-term)	 tool	of	depression	
treatment (Benedetti & Colombo, 2011; Borbely & Wirz-Justice, 1982; Wirz-Justice 
& Van den Hoofdakker, 1999), which improves mood via suppressing SWA and 
increasing homeostatic sleep drive. Both slower rise of SWA during initial stage 
of sleep and incomplete dissipation of SWA found in the group of depressed 
adolescents indicate lower homeostatic sleep drive. 
The analysis of association between severity of depressive symptoms and 
SWA	dissipation	revealed	that	a	flatter	SWA	dissipation	was	associated	with	more	
severe depression symptoms. A negative correlation between SWA dissipation and 
HDRS was found in the frontal (r=-0.505, p<0.05) derivation, but not in the central 
one	(r=-0.437).	This	is	an	interesting	finding	in	terms	of	the	studies	showing	that	
the	distribution	of	 SWA	across	 the	first	 two	NREM	sleep	episodes	 is	associated	
with clinical outcome in depressed adult patients (Ehlers et al., 1996; Kupfer et al., 
1990).
It should be noted that all the above reported results were more pronounced 
in frontal derivation compared to central one. Slow waves during sleep are 
more prevalent in frontal cortex compared to other brain areas (Cajochen et al., 
1999; Huber et al., 2004), which was also observed in our study. Furthermore, 
morphometric and functional brain imaging studies (Arnone et al., 2012; Cooney 
et al., 2010; Drevets et al., 1997; Myers-Schulz & Koenigs, 2012; Rajkowska et al., 
1999), including studies in adolescents and young adults (Ducharme et al., 2014; 
Reynolds et al., 2014), have shown that the frontal cortex, which plays a key role 
in	emotion	regulation,	is	affected	by	depression.	Thus,	our	results	are	in	line	with	
earlier	findings	on	the	involvement	of	frontal	cortex	in	depression,	and	support	the	
idea that sleep regulation and depression might share common neurobiological 
mechanisms (Adrien, 2002; Chang et al., 2014; Taylor et al., 2005). 
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5.4. Role of BDNF Val66Met polymorphism in early life sleep, 
temperament and psychomotor development
Several functional polymorphisms in a number of candidate genes have been 
associated with early development of children’s temperament and psychosocial 
maturation, often predisposing them to various maladaptive outcomes later in life 
(Caspi et al., 2002; Cicchetti et al., 2011; Cutuli et al., 2013; Holmboe et al., 2011). 
However, BDNF gene and its most common single nucleotide polymorphism 
(Val66Met) has not been studied in this regard. Since BDNF Val66Met polymorphism 
is related to neuroplasticity, and the expression of the BDNF Met allele is related to 
impaired BDNF secretion, it seems reasonable to assume that this polymorphism 
could be associated with early life development. Thus, we investigated BDNF 
Val66Met polymorphism in the sample of the Finnish birth cohort CHILD-SLEEP 
(N=1678)	and	studied	 its	association	with	different	parameters,	 including	sleep,	
psychomotor development and temperament.
A total of 1119 infants (572 boys and 547 girls) at the age of 3 months and 994 
(507 boys and 487 girls) at the age of 8 months were analyzed in this study (Table 
8). The genotype frequencies of BDNF Val66Met polymorphism indicated on high 
prevalence	of	individuals	with	Val/Val	genotype	(~70%)	and	very	low	number	of	
Met/Met	individuals	(~1%).
Table 8. Characteristics of the CHILD-SLEEP birth cohort participants
Variable Descriptives at the age of 3 
months
Descriptives at the age of 8 
months
Sample size, n 1119 994
Gender,	male,	n	(%) 572 (51.0) 507 (51.0)
Genotype	frequency,	n	(%)
Val/Val
Val/Met
Met/Met
796 (71.1)
308 (27.5)
15 (1.3)
711 (7.5)
271 (27.3)
12 (1.2)
Since	previous	findings	have	revealed	significant	differences	in	development	
of studied parameters in boys and girls (Gartstein & Rothbart, 2003; Martin et al., 
1997),	we	also	assessed	the	difference	between	genders	in	the	traits	of	interest	in	
the CHILD-SLEEP cohort.
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At the age of 3 months, girls spent more time in sleep during the day 
(322.98±3.96 vs. 307.32±3.86 min, P=0.005; PBonf=0.045), had lower proportion of 
night sleep respective to TST (higher ratio: night sleep/TST) (P=0.046; PBonf>0.05) 
and less number of night awakenings (1.97±1.44 vs. 2.14±1.20, P=0.035; PBonf>0.05) 
than boys (Table 9). Regarding psychomotor development, boys had higher scores 
at gross motor development scale than girls (5.12±0.07 vs. 4.92±0.07, P=0.031; 
PBonf>0.05) (Table 9).
At	 the	 age	 of	 8	 months,	 we	 found	 a	 significant	 difference	 between	 boys	
and	 girls	 in	 two	 psychomotor	 characteristics	 (socioemotional	 and	 fine	 motor	
development)	 and	 in	 temperament	 scale,	 particularly	 in	 negative	 affectivity	
dimension of IBQ-R. Girls showed higher scores in the socioemotional (21.11±0.11 
vs. 20.63±0.11, p=0.001, PBonf=0.016)	 and	 fine	motor	 development	 (25.15±0.16	 vs.	
24.23±0.15, P=2.9x10-5; PBonf=0.00046) scales than boys. Girls demonstrated higher 
scores	than	boys	 in	negative	affectivity	scales	of	 IBQ-R	(3.07±0.03	vs.	2.95±0.03,	
P=0.008; PBonf>0.05	 (Table	 10).	 Similar	 gender	 differences	 in	 IBQ-R	 have	 been	
also reported previously in 6-month old infants (Martin et al., 1997) and in older 
children and adults (Gartstein & Rothbart, 2003). Thus, we can conclude that our 
sample was representative as a normative sample of children.
Taking	 into	account	 these	differences,	 gender	was	 included	as	 a	 factor	 in	
the subsequent analysis for association between BDNF polymorphism and above 
mentioned	developmental	 parameters.	However,	we	 found	 no	 significant	 effect	
of Val66Met BDNF polymorphism on studied sleep parameters and psychomotor 
development of infants at the age of 3 months (P>0.05 for all traits, Table 9) or on 
sleep, psychomotor development and temperament at the age of 8 months (P>0.05 
for all traits, Table 10).
To gain more information about sleep quality of infants at the age of 8 months, 
a subsample (N=57) of infants underwent polysomnographic recordings. We did 
not	find	significant	differences	 in	measured	polysomnographic	parameters	 (SEI	
and WASO) between boys and girls, and the analysis of association between BDNF 
Val66Met	polymorphism	and	polysomnographic	variables	revealed	no	significant	
effect	(P>0.05	for	all	parameters,	Table	10).
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From previous studies in adults it is known that BDNF Val66Met 
polymorphism is associated with anxiety/depression-related temperament 
traits, such as neuroticism (Jylha et al., 2009), but the results of these studies are 
inconsistent (Huennerkopf et al., 2007; Itoh et al., 2004). Some indicate higher 
levels of neuroticism in Val allele homozygous individuals than in Met carriers, 
while others failed to show such association (Tochigi et al., 2006; Wray et al., 
2008); one study found the association in females, but not in males (Itoh et al., 
2004). Moreover, a link between BDNF allelic variation and another temperament 
trait, extraversion, has been found (Terracciano et al., 2010). Furthermore, the 
association between BDNF genotype and adult depression in context of early life 
adverse experience has been shown as well (Buchmann et al., 2013; Liu, 2010; van 
Oostrom	et	al.,	 2012).	However,	our	study	 failed	 to	find	an	association	between	
BDNF genotype and early life temperament or psychomotor development of 
infants. 
Studies regarding the role of Val66Met polymorphism in sleep regulation 
are limited and performed mostly in adults. Val66Met polymorphism has been 
link	with	sleep	efficiency:	Val/Val	genotype	has	been	associated	with	higher	SWA	
in baseline sleep and post sleep deprivation recovery sleep (Bachmann et al., 
2012). Decreased spectral power in alpha and theta ranges were also observed 
in NREM sleep in Met allele carriers (Guindalini et al., 2014). In our study we 
found	no	 significant	association	 between	Val66Met	polymorphism	and	any	of	
the studied sleep parameters based either on parent reports at the age of 3- and 
8 months or on polysomnographic measures in a subsample of infants at the age 
of 8 months.
BDNF is one of the central regulators of early stages of nervous system 
maturation,	and	disturbances	in	its	functions	would	have	severe	effects	for	the	
development (Binder & Scharfman, 2004; Cohen-Cory et al., 2010; Halepoto 
et al., 2014). It has been shown that in immature neurons, BDNF is involved 
in	growth,	differentiation,	maturation	and	survival	processes	while	in	mature	
neurons it plays an important role in synaptic plasticity, augmentation of 
neurotransmission and regulation of receptor sensitivity (Calabrese et al., 
2009; Gonzalez et al., 2016; Numakawa et al., 2010). Based on our results we 
can hypothesize that during critical periods of neuronal development BDNF 
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Val66Met polymorphism is not associated with development of infant’s 
temperament, psychomotor maturation or sleep. However, later in life, the 
effects	of	the	genetic	variant	may	become	evident,	particularly	 in	connection	
with traumatic childhood life events (Aguilera et al., 2009; Buchmann et al., 
2013; Comasco et al., 2013; Gutierrez et al., 2015).
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6. Methodological considerations
I.   In	the	study	on	exon-specific	BDNF expression and methylation, the most 
notable limitation was the small sample size. To estimate the impact of the 
data,	Cohen’s	d	effect	sizes	were	used.	In	the	present	data	set,	group	differences	
showed	medium	effect	sizes.	Hence,	despite	the	low	n,	effect	sizes	reflect	that	
the	significant	differences	between	the	groups	in	the	study	are	relevant.	The	
results	should,	therefore,	be	confirmed	in	studies	with	larger	sample	size.
II. In the cross-fostering experiments both male and female rats were used 
for the study, and females demonstrated high variability in the brain BDNF 
expression.	This	variability	may,	at	least	partially,	be	due	to	different	BDNF	
levels in the course of oestrous cycle (Luine & Frankfurt, 2013). This may 
have	been	reflected	also	in	the	variability	of	sleep	stages,	which	was	reported	
before (Fang & Fishbein, 1996). In the present study, we did not determine the 
phase	of	oestrous	cycle	because	of	potential	stressful	effect	of	this	procedure,	
and	thus	potential	influence	on	the	results.	In	future,	the	studies	should	be	
repeated with evaluation of oestrous cycle in females. Another issue of this 
study is related to corticosterone (stress hormone in rats). Measurements of 
this	hormone	could	have	potentially	clarified	the	stress	level	induced	by	the	
CF treatment.
III. In the study on sleep assessment in depressed adolescent boys, the limitation 
was	 the	small	 sample	size.	The	 results	 should,	 therefore,	 be	confirmed	 in	
studies with larger sample size. The study was performed using only male 
participants. However, it was shown previously that depressed girls may 
show no changes in SWA (Lopez et al., 2012) or even higher SWA (Frey et al., 
2012) as compared to an age- and gender-matched control group. In future, it 
would	be	important	to	be	able	to	have	a	sufficiently	large	sample	that	would	
enable examining both genders in an identical study setting.
IV. In the genetic study, the main issue is most notably the small number of 
infants with two Met alleles (Met/Met group) due to its rare occurrence 
in Caucasian populations. Thus, it is advisable to use bigger sample size 
to reach meaningful number of Met/Met representatives. On the other 
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hand, it is known that allele frequencies in BDNF Val66Met polymorphism 
differ	by	ethnicity	(Pivac	et	al.,	2009;	Verhagen	et	al.,	2010),	so	using	Asian	
populations, where the frequency of the Met allele is much higher compared 
to Caucasians, can be of great interest.
85
7. Summary and Conclusions
1. During spontaneous sleep-wake cycle the modulation of BDNF transcription 
was	 at	 least	 partially	 regulated	 by	 brain	 site	 specific	 DNA	 methylation.	
The dynamics of sleep deprivation-induced BDNF up-regulation in basal 
forebrain and frontal cortex were transcript- and brain area-dependent. 
2. Early life stress events leave a persistent molecular trace in the brain, as in 
the cross-fostering animal study was evidenced by decreased adenosine 
level in the basal forebrain. Only a tendency to lower BDNF gene expression 
was observed in the basal forebrain of cross-fostered rats. This molecular 
“scar” may act as a predisposing factor in development of psychopathologies 
later in life. Sleep, particularly REM sleep, appeared to be the most sensitive 
behavioural indicator of the early life stress events.
3. Adolescent depression was characterized by lower SWA power and its slower 
build	up	in	the	course	of	the	first	NREM	episode	together	with	more	even	
pattern	of	SWA	dissipation	through	the	night	in	frontal	area.	These	findings	
suggest that homeostatic sleep regulation may be impaired in adolescent 
depression. Since more pronounced changes were observed in frontal area it 
support the idea that sleep regulation and depression might share common 
neurobiological mechanisms.
4. Finally,	we	could	 not	 find	any	evidence	 for	 the	 involvement	of	 the	BDNF 
Val66Met polymorphism neither in early life development of psychomotor 
functions and sleep in 3- and 8-months old infants, nor in temperament in 
8-months old infants.
Our results from animal and human adolescent studies (II, III) indicate that 
sleep	is	the	most	sensitive	indicator	of	early	life	stress.	Adenosine	deficiency	in	the	
basal forebrain, as was shown in the animal model of early life stress (II), is one of 
the possible mechanisms leading to high vulnerability to sleep problems, and it is a 
permanent trace left in the brain by early life stress. In its turn, BDNF being highly 
involved in sleep regulation (I) may not be a best marker of early life stress (II) 
and its polymorphism is not associated with sleep and psychomotor development 
during early life stage (IV).
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Assessing	adenosine	or	BDNF	levels	is	difficult	in	clinical	practice	and	requires	
blood	sampling.	Moreover,	it	is	uncertain	how	well	peripheral	measurements	reflect	
central concentrations in the brain. In this regard, sleep can be used in clinical 
practice as a non-invasive biomarker for early diagnosis of depressive disorder 
as a consequence of early life stress. Early-onset sleep problems should be taken 
seriously in clinical practise, and access to psychiatric examination should be easily 
available, in order to address the possible psychiatric problems at their early phase.
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